[go: up one dir, main page]

WO2025006691A2 - Compositions poreuses d'alpha-1,3-glucane - Google Patents

Compositions poreuses d'alpha-1,3-glucane Download PDF

Info

Publication number
WO2025006691A2
WO2025006691A2 PCT/US2024/035735 US2024035735W WO2025006691A2 WO 2025006691 A2 WO2025006691 A2 WO 2025006691A2 US 2024035735 W US2024035735 W US 2024035735W WO 2025006691 A2 WO2025006691 A2 WO 2025006691A2
Authority
WO
WIPO (PCT)
Prior art keywords
glucan
aerogel
alpha
water
composition
Prior art date
Application number
PCT/US2024/035735
Other languages
English (en)
Other versions
WO2025006691A3 (fr
Inventor
Sefiu A. RASAKI
Steven L. Bryant
Milana Trifkovic
Natnael Behabtu
Christian Peter Lenges
Original Assignee
Nutrition & Biosciences USA 4, Inc.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nutrition & Biosciences USA 4, Inc. filed Critical Nutrition & Biosciences USA 4, Inc.
Publication of WO2025006691A2 publication Critical patent/WO2025006691A2/fr
Publication of WO2025006691A3 publication Critical patent/WO2025006691A3/fr

Links

Classifications

    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
    • B01J13/00—Colloid chemistry, e.g. the production of colloidal materials or their solutions, not otherwise provided for; Making microcapsules or microballoons
    • B01J13/0091—Preparation of aerogels, e.g. xerogels
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
    • B01J20/00—Solid sorbent compositions or filter aid compositions; Sorbents for chromatography; Processes for preparing, regenerating or reactivating thereof
    • B01J20/22—Solid sorbent compositions or filter aid compositions; Sorbents for chromatography; Processes for preparing, regenerating or reactivating thereof comprising organic material
    • B01J20/24—Naturally occurring macromolecular compounds, e.g. humic acids or their derivatives
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
    • B01J20/00—Solid sorbent compositions or filter aid compositions; Sorbents for chromatography; Processes for preparing, regenerating or reactivating thereof
    • B01J20/28—Solid sorbent compositions or filter aid compositions; Sorbents for chromatography; Processes for preparing, regenerating or reactivating thereof characterised by their form or physical properties
    • B01J20/28014—Solid sorbent compositions or filter aid compositions; Sorbents for chromatography; Processes for preparing, regenerating or reactivating thereof characterised by their form or physical properties characterised by their form
    • B01J20/28047—Gels

Definitions

  • the present disclosure is in the field of polysaccharides.
  • the disclosure pertains to porous compositions that comprise insoluble alpha-glucan having alpha-1 ,3 glycosidic linkages.
  • Aerogels and hydrogels are examples of porous compositions herein.
  • polysaccharides that are biodegradable and that can be made economically from renewably sourced feedstocks.
  • One such polysaccharide is alpha- 1 ,3-glucan, an insoluble glucan polymer characterized by having alpha-1 , 3-glycosidic linkages.
  • This polymer has been prepared, for example, using a glucosyltransferase enzyme isolated from Streptococcus salivarius (Simpson et al., Microbiology 141 : 1451 - 1460, 1995).
  • U.S. Patent No. 7000000 disclosed the preparation of a spun fiber from enzymatically produced alpha-1 ,3-glucan.
  • Aerogel is a solid-state porous material derived from a gel that has been treated to replace its liquid contents with air.
  • aerogels can contain at least about 99 wt% air, therefore qualifying them as ultra-light weight materials. Aerogels are useful in applications of absorption/adsorption, drug delivery and catalysis, for example, due to their high surface area and porosity, while their insulating properties also render them useful in thermal insulation and packaging applications.
  • glucan polymers such as cellulose and chitosan have previously been tested in synthesizing aerogels, but these and other polysaccharides-based aerogels have generally been found to be prone to issues of structural discontinuity, uneven pore distribution, and formation of large pores that can cause significant shrinkage, structure collapse, and brittleness. These features can negatively impact the water retention capacity of an aerogel.
  • aerogels made with formulations that allow better functionality are desired. Aerogels comprising alpha-1 , 3-glucan are disclosed herein, for example, to help address this need.
  • the present disclosure concerns a composition
  • a composition comprising an aerogel, wherein the aerogel comprises at least a water-insoluble alpha-glucan and a metal oxide, wherein at least about 50% of the glycosidic linkages of the insoluble alphaglucan are alpha-1 ,3 linkages, and wherein the metal oxide is calcium oxide (CaO), magnesium oxide (MgO), or titanium dioxide (TiC>2).
  • the aerogel comprises at least a water-insoluble alpha-glucan and a metal oxide, wherein at least about 50% of the glycosidic linkages of the insoluble alphaglucan are alpha-1 ,3 linkages, and wherein the metal oxide is calcium oxide (CaO), magnesium oxide (MgO), or titanium dioxide (TiC>2).
  • the present disclosure concerns an aqueous caustic solution comprising (i) an aqueous caustic solvent, (ii) a water-insoluble alpha-glucan, and (iii) a metal hydroxide, wherein at least about 50% of the glycosidic linkages of the water-insoluble alpha-glucan are alpha-1 ,3 glycosidic linkages, wherein the waterinsoluble alpha-glucan is dissolved in the aqueous caustic solvent and the metal hydroxide is not dissolved in the aqueous caustic solvent, and wherein the metal hydroxide is calcium hydroxide, magnesium hydroxide, or titanium hydroxide.
  • the present disclosure concerns a method/process of producing an aerogel herein, the method comprising: (a) providing an aqueous caustic solution herein, (b) putting the aqueous caustic solution into a desired form, (c) chemically or ionically modifying the aqueous caustic solvent such that the waterinsoluble alpha-glucan and the metal hydroxide are undissolved in the solvent, whereby a hydrogel is produced, and (d) removing all of the water, or most of the water, from the hydrogel, whereby an aerogel is produced.
  • FIG. 1 This figure represents the typical scheme used herein for synthesizing hybrid hydrogels and hybrid aerogels. Refer to Examples.
  • FIG. 2 SEM imaging of neat glucan aerogel (a) and hybrid aerogels having magnesium oxide (b), calcium oxide (c), or titanium oxide (d). Each image contains a 50- .m reference bar and an inset image with a 5- .m reference bar. Refer to Examples.
  • FIG. 3 Water absorption by hybrid glucan and neat glucan aerogels over time.
  • the inset chart shows water absorption of the aerogels under load.
  • neat glucan main chart: triangles of lowest line, as indicated; inset chart: diamonds of lowest line, as indicated
  • MgO-glucan circles
  • CaO-glucan triangles
  • TiO2-glucan squares.
  • FIG. 4 Saline absorption by hybrid glucan and neat glucan aerogels over time.
  • the inset chart shows saline absorption of the aerogels under load.
  • neat glucan main chart: diamonds of lowest line, as indicated; inset chart: squares of lowest line, as indicated), MgO-glucan (circles), CaO-glucan (triangles), TiO2-glucan (squares).
  • FIG. 5A Glycerol: water (1 :10) (v/v) absorption by hybrid glucan and neat (pure) glucan aerogels over time. Key: neat (pure) glucan (diamonds), MgO-glucan (circles), CaO- glucan (triangles), TiO2-glucan (squares). Refer to Examples.
  • FIG. 5B Glycerol: water (1 :1) (v/v) absorption by hybrid glucan and neat (pure) glucan aerogels, under load, over time. Key: neat (pure) glucan (diamonds), MgO-glucan (circles), CaO-glucan (triangles), TiO2-glucan (squares). Refer to Examples.
  • FIG. 5C Glycerokwater (1 :10, 1 :1 , or 5:1) (v/v) absorption by hybrid glucan (MgO-, CaO-, or TiO2-glucan) and neat (pure) glucan aerogels at 100 seconds. Absorption capacities of a commercial diaper and commercial pad were also measured. The viscosity of each glycerol-water solution is listed.
  • a “glucan” herein is a type of polysaccharide that is a polymer of glucose (polyglucose).
  • a glucan can be comprised of, for example, about, or at least about, 90%, 91 %, 92%, 93%, 94%, 95%, 96%, 97%, 98%, 99%, or 100% by weight glucose monomeric units.
  • An example of a glucan herein is alpha-glucan.
  • alpha-glucan is a polymer comprising glucose monomeric units linked together by alpha-glycosidic linkages.
  • the glycosidic linkages of an alpha-glucan herein are about, or at least about, 80%, 81%, 82%, 83%, 84%, 85%, 86%, 87%, 88%, 89%, 90%, 91%, 92%, 93%, 94%, 95%, 96%, 97%, 98%, 99%, or 100% alpha-glycosidic linkages.
  • An example of an alpha-glucan polymer herein is alpha-1 , 3-glucan.
  • saccharide and other like terms herein refer to monosaccharides and/or disaccharides/oligosaccharides, unless otherwise noted.
  • a “disaccharide” herein refers to a carbohydrate having two monosaccharides joined by a glycosidic linkage.
  • An “oligosaccharide” herein can refer to a carbohydrate having 3 to 15 monosaccharides, for example, joined by glycosidic linkages.
  • An oligosaccharide can also be referred to as an “oligomer”.
  • Monosaccharides e.g., glucose and/or fructose
  • comprised within disaccharides/oligosaccharides can be referred to as “monomeric units”, “monosaccharide units”, or other like terms.
  • Alpha-1 , 3-glucan is an alpha-glucan comprising glucose monomeric units linked together by glycosidic linkages, wherein at least about 50% of the glycosidic linkages are alpha-1 ,3.
  • Alpha-1 , 3-glucan in some aspects comprises about, or at least about, 90%, 95%, or 100% alpha-1 ,3 glycosidic linkages.
  • Most or all of the other linkages, if present, in alpha-1 , 3-glucan herein typically are alpha-1 ,6, though some linkages may also be alpha-1 ,2 and/or alpha-1 ,4.
  • Alpha-1 ,3- glucan herein is typically water-insoluble.
  • linkages refer to the covalent bonds connecting the sugar monomers within a saccharide compound (oligosaccharides and/or polysaccharides).
  • examples of glycosidic linkages include 1 ,6- alpha-D-glycosidic linkages (herein also referred to as “alpha-1 ,6” linkages), 1 ,3-alpha-D- glycosidic linkages (herein also referred to as “alpha-1 ,3” linkages), 1 ,4-alpha-D- glycosidic linkages (herein also referred to as “alpha-1 ,4” linkages), and 1 ,2-alpha-D- glycosidic linkages (herein also referred to as “alpha-1 ,2” linkages).
  • the glycosidic linkages of a glucan polymer herein can also be referred to as “glucosidic linkages”.
  • alpha-D-D-(alpha-1 ,6” linkages 1 ,3-alpha-D- glyco
  • the glycosidic linkage profile of an alpha-glucan can be determined using any method known in the art.
  • a linkage profile can be determined using methods using nuclear magnetic resonance (NMR) spectroscopy (e.g., 13 C NMR and/or 1 H NMR).
  • NMR nuclear magnetic resonance
  • 13 C NMR and/or 1 H NMR nuclear magnetic resonance
  • molecular weight of an alpha-glucan herein can be represented as weightaverage molecular weight (Mw) or number-average molecular weight (Mn), the units of which are in Daltons (Da) or grams/mole.
  • molecular weight can be represented as DPw (weight average degree of polymerization) or DPn (number average degree of polymerization).
  • molecular weight can sometimes be provided as “DP” (degree of polymerization), which simply refers to the number of glucoses comprised within the alpha-glucan on an individual molecule basis.
  • DP degree of polymerization
  • HPLC high-pressure liquid chromatography
  • SEC size exclusion chromatography
  • GPC gel permeation chromatography
  • Mw of a polymer can be determined by other techniques such as static light scattering, mass spectrometry, MALDI-TOF (matrix-assisted laser desorption/ionization time-of-flight), small angle X-ray or neutron scattering, or ultracentrifugation.
  • the Mn of a polymer can be determined by various colligative property methods such as vapor pressure osmometry, end-group determination by spectroscopic methods such as proton NMR, proton FTIR, or UV-Vis.
  • hydrogel and like terms as used herein refer to a biphasic material/composition of porous, permeable solids and typically at least 10% by weight or volume of aqueous fluid (“interstitial aqueous fluid”) (typically 100 wt% water, or an aqueous liquid of water and one or more other types of liquid such as a suitable polar organic solvent [e.g., ethanol, isopropanol]).
  • aqueous fluid typically 100 wt% water, or an aqueous liquid of water and one or more other types of liquid such as a suitable polar organic solvent [e.g., ethanol, isopropanol]).
  • the hydrogel solids component is a waterinsoluble three-dimensional network comprising at least alpha-1 , 3-glucan and a metal oxide such as calcium hydroxide [Ca(OH) 2 ], magnesium hydroxide [Mg(OH) 2 ], or titanium hydroxide [Ti(OH) 4 ] (or any other hydroxide of an alkali earth metal or transition metal, which metal hydroxide is suitable for producing a hydrogel of alpha-1 , 3-glucan).
  • a metal oxide such as calcium hydroxide [Ca(OH) 2 ], magnesium hydroxide [Mg(OH) 2 ], or titanium hydroxide [Ti(OH) 4 ] (or any other hydroxide of an alkali earth metal or transition metal, which metal hydroxide is suitable for producing a hydrogel of alpha-1 , 3-glucan).
  • an aerogel refers to a porous material/composition derived from an aqueous gel (hydrogel) from which the liquid component (typically of water only, but optionally further comprising one or more other types of liquid) has been replaced with a gas (e.g., standard atmospheric air).
  • a gas e.g., standard atmospheric air
  • an aerogel typically is a dry/dried composition, though it can be made wet in water absorption applications.
  • An aerogel herein generally is a nanoporous material/composition with various properties such as low density, low thermal conductivity, enhanced strength/stiffness, and/or high specific internal surface area.
  • An aerogel of the present disclosure comprises at least alpha-1 , 3-glucan and a metal oxide such as calcium oxide (CaO), magnesium oxide (MgO), or titanium dioxide (TiO 2 ) (or any other oxide of an alkali earth metal or transition metal, which metal oxide is suitable for producing an aerogel of alpha-1 , 3-glucan).
  • a metal oxide such as calcium oxide (CaO), magnesium oxide (MgO), or titanium dioxide (TiO 2 ) (or any other oxide of an alkali earth metal or transition metal, which metal oxide is suitable for producing an aerogel of alpha-1 , 3-glucan).
  • a metal oxide such as calcium oxide (CaO), magnesium oxide (MgO), or titanium dioxide (TiO 2 ) (or any other oxide of an alkali earth metal or transition metal, which metal oxide is suitable for producing an aerogel of alpha-1 , 3-glucan).
  • a composition can be characterized to have been “comminuted”, meaning that the composition has been reduced from a larger size to particles (e.g., by crushing, grinding, pulverizing, and/or any other suitable means).
  • Particle size in some aspects can refer to particle diameter and/or the length of the longest particle dimension. The average size can be based on the average of diameters and/or longest particle dimensions of at least 50, 100, 500, 1000, 2500, 5000, or 10000 or more particles, for example.
  • Particle size herein can be measured by a process comprising light scattering or electrical impedance change (e.g., using a Coulter Counter), for example, such as described in any of U.S. Patent Nos. 6091492, 6741350, or 9297737 (each incorporated herein by reference).
  • Particle size herein can optionally be expressed by a “Dio”, “Dso”, “D 90 ”, etc. value; for example, a D 5 o value is the diameter for which 50% by weight of the particles in a composition (e.g., a powder of an aerogel herein) have a diameter under that diameter, and 50% by weight of the particles have a diameter greater than that diameter.
  • hydrogen bond refers to electromagnetic attraction that is not a covalent bond, ionic bond, or van der Waals forces.
  • a hydrogen bond is weaker than ionic and covalent bonds, but stronger than van der Waals forces.
  • a hydrogen atom involved in a hydrogen bond herein is directly bonded to an oxygen atom (of a hydroxyl group) of a glucose monomeric unit of an alpha-glucan, which hydrogen atom interacts electrostatically with an oxygen atom of a metal oxide.
  • This hydrogen bonding can optionally be characterized as intermolecular, since it occurs between an alpha-glucan molecule and a metal oxide molecule.
  • aqueous liquid can refer to water or an aqueous solution.
  • An “aqueous solution” herein can comprise one or more dissolved salts, where the maximal total salt concentration can be about 3.5 wt% in some aspects.
  • aqueous liquids herein typically comprise water as the only solvent in the liquid, an aqueous liquid can optionally comprise one or more other solvents (e.g., polar organic solvent) that are miscible in water.
  • an aqueous solution can comprise a solvent having at least about 10 wt% water.
  • aqueous composition herein has a liquid component that comprises about, or at least about, 10, 20, 30, 40, 50, 60, 70, 80, 90, 95, 99, or 100 wt% water, for example.
  • aqueous compositions include some mixtures, solutions, dispersions (e.g., colloidal dispersions), suspensions and emulsions, for example.
  • alpha-glucan that is “insoluble”, “aqueous-insoluble”, “water-insoluble” (and like terms) (e.g., alpha-1 , 3-glucan with a DP of 8 or higher) herein does not dissolve (or does not appreciably dissolve) in water or other aqueous conditions, optionally where the aqueous conditions are at a pH of 4-9 (e.g., pH 6-8) and/or temperature of about 1 to 130 °C (e.g., 20-25 °C).
  • aqueous-insoluble e.g., alpha-1 , 3-glucan with a DP of 8 or higher
  • aqueous-insoluble alpha-glucan dissolves in 1000 milliliters of such aqueous conditions (e.g., water at 23 °C).
  • glucans such as certain oligosaccharides herein that are “soluble”, “aqueous-soluble”, “water-soluble” and the like (e.g., alpha-1 ,3-glucan with a DP less than 8) appreciably dissolve under these conditions.
  • a “dope solution”, “dope”, “caustic solution”, “basic solution”, “alkaline solution” and the like herein refer to a solution (typically aqueous with pH > 11) in which, at least, a water-insoluble alpha-glucan (e.g., being insoluble in aqueous solution of pH 4-9) is dissolved.
  • freeze-drying refers to a process in which a wet composition (e.g., a hydrogel herein) (e.g., wet with water, polar organic solvent, or combination thereof) is rapidly frozen (freezing step), and then subjected to a high vacuum (to provide lower air pressure) to remove frozen water by sublimation (primary drying step).
  • a wet composition e.g., a hydrogel herein
  • Freeze-drying herein can optionally comprise a secondary drying step in which the temperature is raised higher (and pressure typically lowered further) than in the primary drying phase.
  • supercritical drying refers to a process by which the liquid (e.g., water, polar organic solvent, or combination thereof) in a wet composition (e.g., a hydrogel herein) is transformed into gas in the absence of surface tension and capillary stress.
  • supercritical drying can be performed using supercritical carbon dioxide (CO2), for example.
  • Supercritical CO2 is a fluid state of CO2 where it is held at or above its critical temperature and critical pressure.
  • sequence identity As used herein with respect to a polypeptide amino acid sequence (e.g., that of a glucosyltransferase) can be as defined and determined in U.S. Patent Appl. Publ. No. 2017/0002336, which is incorporated herein by reference.
  • the variant amino acid sequence has the same function/activity of the disclosed sequence, or at least about 80%, 81 %, 82%, 83%, 84%, 85%, 86%, 87%, 88%, 89%, 90%, 91%, 92%, 93%, 94%, 95%, 96%, 97%, 98%, or 99% of the function/activity of the disclosed sequence.
  • a composition herein such as an aerogel that is “dry” or “dried” typically has less than about 3, 2, 1 , 0.5, or 0.1 wt% water comprised therein.
  • viscosity refers to the measure of the extent to which a fluid (aqueous or non-aqueous) resists a force tending to cause it to flow.
  • Various units of viscosity that can be used herein include centipoise (cP, cps) and Pascal-second (Pa s), for example.
  • cP, cps centipoise
  • Pa s Pascal-second
  • Viscosity can be reported as “intrinsic viscosity” (IV, r
  • IV can be measured, in part, by dissolving glucan polymer (optionally dissolved at about 100 °C for at least 2, 4, or 8 hours) in DMSO with about 0.9 to 2.5 wt% (e.g., 1 , 2, 1-2 wt%) LiCI, for example. IV herein can optionally be used as a relative measure of molecular weight.
  • absorb refers to the action of taking up (soaking up) a liquid (e.g., aqueous liquid). Absorption by a composition as presently disclosed can be measured in terms of water absorption capacity as disclosed herein, for example.
  • An “absorbent” herein is a product/composition that can exhibit absorption when placed in contact with water or other aqueous composition/liquid.
  • under load and like terms herein characterize conditions in which pressure or weight is applied to a composition or product herein.
  • under-load conditions can act to reduce the amount the absorbed aqueous liquid (e.g., some absorbed aqueous liquid can be forced out of the composition under load).
  • polar organic solvent and “water-miscible organic solvent” (and like terms) are used interchangeably herein.
  • a polar organic solvent can be dissolved in water or an aqueous solution. Thus, a polar organic solvent does not separate out into a different phase when added to water or an aqueous solution.
  • a polar organic solvent contains carbon and at least one heteroatom (i.e. , non-carbon or -hydrogen atom) such as oxygen, nitrogen, sulfur, or phosphorous. This contrasts with non-polar organic solvents, which generally comprise only carbon and hydrogen atoms.
  • a polar organic solvent typically has a dielectric constant greater than about 4.
  • a polar organic solvent contains dipoles due to polar bonds.
  • protic polar organic solvent refers to a polar organic solvent that has one or more suitably labile hydrogen atoms that can form hydrogen bonds.
  • a protic polar organic solvent generally contains hydrogen atoms bonded to an atom with electronegative character; e.g., there are one or more O-H, N-H, and/or S-H bonds.
  • aprotic polar organic solvent refers to a polar organic solvent that does not have suitably labile hydrogen atoms that can form hydrogen bonds.
  • An aprotic polar organic solvent does not contain hydrogen atoms bonded to an atom with electronegative character; e.g., there are no O-H, N-H, or S-H bonds.
  • household care product typically refer to products, goods and services relating to the treatment, cleaning, caring, and/or conditioning of a home and its contents.
  • the foregoing include, for example, chemicals, compositions, products, or combinations thereof having application in such care.
  • personal care product typically refer to products, goods and services relating to the treatment, cleaning, cleansing, caring, or conditioning of a person.
  • the foregoing include, for example, chemicals, compositions, products, or combinations thereof having application in such care.
  • medical product typically refer to products, goods and services relating to the diagnosis, treatment, and/or care of patients.
  • industrial product typically refer to products, goods and services used in industrial and/or institutional settings, but typically not by individual consumers.
  • a “pharmaceutical product”, “medicine”, “medication”, “drug” or like term herein refers to a composition used to treat disease or injury, and can be administered enterally or parenterally.
  • percent by volume percent by volume of a solute in a solution
  • percent by volume of a solute in a solution can be determined using the formula: [(volume of solute)/(volume of solution)] x 100%.
  • Percent by weight refers to the percentage of a material on a mass basis as it is comprised in a composition, mixture, or solution, for example.
  • Weight/volume percent can be calculated as: ((mass [g] of material)/(total volume [mL] of the material plus the liquid in which the material is placed)) x 100%.
  • the material can be insoluble in the liquid (i.e. , be a solid phase in a liquid phase, such as with a dispersion), or soluble in the liquid (i.e., be a solute dissolved in the liquid).
  • isolated means a substance (or process) in a form or environment that does not occur in nature.
  • Non-limiting examples of an isolated substance includes any aerogel, hydrogel, or caustic solution herein. It is believed that the embodiments disclosed herein are synthetic/man-made (could not have been made or practiced except for human intervention/involvement), and/or have properties that are not naturally occurring.
  • the term “increased” as used herein can refer to a quantity or activity that is at least about 1 %, 2%, 3%, 4%, 5%, 6%, 7%, 8%, 9%, 10%, 11%, 12%, 13%, 14%, 15%, 16%, 17%, 18%, 19%, 20%, 50%, 100%, or 200% more than the quantity or activity for which the increased quantity or activity is being compared.
  • the terms “increased”, “elevated”, “enhanced”, “greater than”, “improved” and the like are used interchangeably herein.
  • composition/product comprising at least an aerogel (or foam/solid foam, or sponge/solid sponge, e.g.), wherein the aerogel comprises at least a water-insoluble alpha-glucan and a metal oxide, wherein at least about 50% of the glycosidic linkages of the insoluble alpha-glucan are alpha-1 ,3 linkages, and wherein the metal oxide is calcium oxide (CaO), magnesium oxide (MgO), or titanium dioxide (TiC>2) (or any other suitable oxide of an alkali earth metal or transition metal).
  • aerogel or foam/solid foam, or sponge/solid sponge, e.g.
  • the aerogel comprises at least a water-insoluble alpha-glucan and a metal oxide, wherein at least about 50% of the glycosidic linkages of the insoluble alpha-glucan are alpha-1 ,3 linkages, and wherein the metal oxide is calcium oxide (CaO), magnesium oxide (MgO), or titanium dioxide (TiC>2) (or any other suitable oxide of an alkali
  • an insoluble alpha-glucan comprises about, or at least about, 50%, 60%, 70%, 80%, 85%, 86%, 87%, 88%, 89%, 90%, 91 %, 92%, 93%, 94%, 95%, 96%, 97%, 98%, 99%, 99.5%, or 100% alpha-1 ,3 glycosidic linkages (i.e., the alphaglucan is an alpha-1 , 3-glucan).
  • an insoluble alpha-glucan has about, or less than about, 50%, 40%, 30%, 20%, 15%, 10%, 9%, 8%, 7%, 6%, 5%, 4%, 3%, 2%, 1%, 0.5%, or 0% glycosidic linkages that are not alpha-1 ,3.
  • the glycosidic linkages that are not alpha-1 ,3 are mostly or entirely alpha-1 ,6.
  • an insoluble alpha-glucan has no branch points or less than about 5%, 4%, 3%, 2%, or 1% branch points as a percent of the glycosidic linkages in the alpha-glucan.
  • the DPw, DPn, or DP of an insoluble alpha-glucan in some aspects can be about, at least about, or less than about, 10, 15, 25, 50, 75, 100, 150, 200, 300, 400, 500, 600, 700, 800, 900, 1000, 1100, 1200, 1300, 1400, 1500, 1600, 1700, 1800, 1900, 2000, 2500, 3000, 3500, or 4000.
  • DPw, DPn, or DP can optionally be expressed as a range between any two of these values.
  • the DPw, DPn, or DP can be about 50-1600, 100-1600, 200-1600, 300-1600, 400-1600, 500-1600, 600-1600, 700- 1600, 50-1250, 100-1250, 200-1250, 300-1250, 400-1250, 500-1250, 600-1250, 700- 1250, 50-1000, 100-1000, 200-1000, 300-1000, 400-1000, 500-1000, 600-1000, 700- 1000, 50-900, 100-900, 200-900, 300-900, 400-900, 500-900, 600-900, 700-900, 600- 800, or 600-750.
  • the DPw, DPn, or DP can be about 15- 100, 25-100, 35-100, 15-80, 25-80, 35-80, 15-60, 25-60, 35-60, 15-55, 25-55, 35-55, 15- 50, 25-50, 35-50, 35-45, 35-40, 40-100, 40-80, 40-60, 40-55, 40-50, 45-60, 45-55, 45-50, 15-35, 20-35, 15-30, or 20-30.
  • the DPw, DPn, or DP can be about 100-600, 100-500, 100-400, 100-300, 200-600, 200-500, 200-400, or 200-300.
  • an insoluble alpha-glucan can have a high molecular weight as reflected by high intrinsic viscosity (IV); e.g., IV can be about, or at least about, 6, 7, 8, 9, 10, 11 , 12, 13, 14, 15, 16, 17, 18, 19, 20, 21 , 22, 6-8, 6-7, 6-22, 6-20, 6-17, 6-15, 6-12, 10-22, 10-20, 10-17, 10-15, 10-12, 12-22, 12-20, 12-17, or 12-15 dL/g (for comparison purposes, note that the IV of insoluble alpha-glucan with at least 90% (e.g., about 99% or 100%) alpha-1 ,3 linkages and a DPw of about 800 has an IV of about 2-2.5 dL/g). IV herein can be as measured with insoluble alpha-glucan polymer dissolved in DMSO with about 0.9 to 2.5 wt% (e.g., 1 , 2, 1-2 wt%) LiCI, for example.
  • IV can be as measured with insoluble alpha-glucan polymer
  • An insoluble alpha-glucan herein can be as disclosed (e.g., molecular weight, linkage profile, and/or production method), for example, in U.S. Patent Nos. 7000000, 8871474, 10301604, or 10260053, or U.S. Patent Appl. Publ. Nos. 2019/0112456, 2019/0078062, 2019/0078063, 2018/0340199, 2018/0021238, 2018/0273731 , 2017/0002335, 2015/0232819, 2015/0064748, 2020/0165360, 2020/0131281 , 2019/0276806, or 2019/0185893, which are each incorporated herein by reference.
  • U.S. Patent Nos. 7000000, 8871474, 10301604, or 10260053 or U.S. Patent Appl. Publ. Nos. 2019/0112456, 2019/0078062, 2019/0078063, 2018/0340199, 2018/0021238, 2018/0273731 , 2017/0002335, 2015
  • An insoluble alpha-glucan can be produced, for example, by an enzymatic reaction comprising at least water, sucrose and a glucosyltransferase enzyme that synthesizes the insoluble alpha-glucan.
  • Glucosyltransferases, reaction conditions, and/or processes contemplated to be useful for producing insoluble alpha-glucan can be as disclosed in any of the foregoing references.
  • a glucosyltransferase enzyme for producing an insoluble alphaglucan herein can comprise an amino acid sequence that is 100% identical to, or at least 90%, 91%, 92%, 93%, 94%, 95%, 96%, 97%, 98%, 98.5%, 99%, or 99.5% identical to, SEQ ID NO:2, 4, 6, 8, 10, 12, 14, 16, 18, 20, 26, 28, 30, 34, or 59, or amino acid residues 55-960 of SEQ ID NO:4, residues 54-957 of SEQ ID NO:65, residues 55-960 of SEQ ID NO:30, residues 55-960 of SEQ ID NO:28, or residues 55-960 of SEQ ID NO:20, and have glucosyltransferase activity; these amino acid sequences are disclosed in U.S.
  • a glucosyltransferase enzyme comprising SEQ ID NO:2, 4, 8, 10, 14, 20, 26, 28, 30, 34, or amino acid residues 55-960 of SEQ ID NO:4, residues 54-957 of SEQ ID NO:65, residues 55-960 of SEQ ID NO:30, residues 55-960 of SEQ ID NO:28, or residues 55-960 of SEQ ID NO:20, can synthesize insoluble alpha-glucan comprising at least about 90% (-100%) alpha-1 ,3 linkages.
  • insoluble alpha-glucan typically does not have any chemical derivatization (e.g., etherification, esterification, phosphorylation, sulfation, oxidation, carbamation) (e.g., no substitution of hydrogens of glucan hydroxyl groups with a non-sugar chemical group).
  • insoluble alpha-glucan can be a charged (e.g., cationic or anionic) derivative of an alpha-glucan as disclosed herein.
  • the DoS of such a derivative typically is less than about 0.3, 0.25, 0.2, 0.15, 0.1 , or 0.05.
  • the type of derivative can be any of the foregoing derivatives (e.g., ether, ester).
  • insoluble alpha-glucan herein is enzymatically derived in an inert vessel (typically under cell-free conditions) and is not derived from a cell wall (e.g., fungal cell wall).
  • a metal oxide in some aspects can be calcium oxide (CaO), magnesium oxide (MgO), or titanium dioxide (TiO 2 ). It is noted for reference purposes that titanium is a transition metal and calcium and magnesium are alkali earth metals. Thus, it is contemplated that a metal oxide herein can be another type of alkali earth metal oxide or transition metal oxide, for example, which metal oxide is suitable for forming an aerogel with a water-insoluble alpha-glucan of the present disclosure. Typically, an aerogel herein has one metal oxide, but in some cases an aerogel can have two or more metal oxides (e.g., CaO and MgO, CaO and TiO 2 , MgO and TiO 2 ). A metal oxide herein, as comprised in an aerogel, can optionally be characterized as being an in s/Yu-generated metal oxide, given how an aerogel can be produced (e.g., as disclosed herein).
  • a metal oxide component of an aerogel as presently disclosed typically interacts with water-insoluble alpha-glucan via hydrogen bonding.
  • Hydrogen bonding can be multivalent, for example, such as when TiC>2 is used as a metal oxide.
  • An aerogel or hydrogel herein typically does not contain any covalent crosslinking, whether between alpha-glucan molecules (intra- or inter-molecular) or between alpha-glucan and a metal oxide or metal hydroxide.
  • An aerogel herein can comprise about, or less than about, 20, 15, 10, 7.5, 6, 5, 4, 3, 2.5, 2, 1 , 0.5, 0.5-10, 0.5-5, 0.5-4, 0.5-3, 0.5-2.5, 1-10, 1-5, 1-4, 1-3, 1-2.5, or 1.5-2.5 wt% of a metal oxide herein (or combination of metal oxides herein), for example.
  • the distribution of metal oxide in an aerogel typically is of uniform distribution.
  • the balance of the mass of an aerogel is of water-insoluble alpha-glucan (i.e., such an aerogel can be characterized as consisting of water-insoluble alpha-glucan and metal oxide).
  • an aerogel can comprise one or more other components (solids) in addition to water-insoluble alpha-glucan and metal oxide.
  • An aerogel can comprise about, or at least about, 80, 85, 90, 92.5, 94, 95, 96, 97, 97.5, 98, 99, or 99.5 wt% of water-insoluble alpha-glucan, in some aspects.
  • An aerogel in some aspects does not comprise polyurethane or any other organic polymer (aside for the insoluble alpha-glucan), and/or does not comprise silica.
  • the foregoing content amounts (wt%’s) can be with respect to the dry solids of an aerogel.
  • any solids component of an aerogel herein typically is borne from its inclusion (or in situ generation) in a process of making the aerogel (i.e., a solid component typically is not one that is present by virtue of having been absorbed into the aerogel, such as from having used an aerogel in an absorption method and then drying it).
  • a solid component typically is not one that is present by virtue of having been absorbed into the aerogel, such as from having used an aerogel in an absorption method and then drying it).
  • an aerogel as produced herein typically is dry/dried (before its use in an aqueous liquid absorption method herein) typically is dry/dried (before its use in an aqueous liquid absorption method herein), it can optionally contain a trace amount of water (e.g., absorbed from atmosphere) (e.g., ⁇ 2, 1 , 0.5, or 0.1 wt% of the aerogel).
  • a hydrogel herein can comprise any of the foregoing content amounts of water-insoluble alphaglucan and of metal hydroxide that can be used to provide any of the foregoing metal oxides, where the content amount is on a dry solids basis (dsb) (alternatively referred to as dry weight basis, dwb).
  • dsb dry solids basis
  • dwb dry weight basis
  • An aerogel herein is porous, typically with about, or at least about, 90%, 95%, 96%, 97%, 98%, 99%, 99.5%, 99.8%, or 99.9% porosity. Percent porosity herein can be determined by dividing the total volume of all the aerogel voids by the total volume of the aerogel itself, and multiplying by 100%.
  • An aerogel of the present disclosure typically has an open-cell pore structure.
  • the cells of an aerogel herein can be continuous, or semi-continuous (e.g., at least about 20%, 30%, 40%, 50%, 60%, 70%, 80%, or 90% of the pores are continuous with at least one immediately adjacent pore), for example (any two pores can be characterized as being continuous with each other if there is an open passage connecting them).
  • Pores herein are typically present throughout the entire aerogel in a uniform manner.
  • an aerogel herein does not comprise closed-cell pore structures (i.e. , pores that are completely closed off and not continuous with any adjacent pores), or has less than 5% or 1% of pores that are closed-cell pores.
  • the pore volume per aerogel mass can be about 0.10-0.15, 0.11-0.15, 0.12-0.15, 0.13-0.15, 0.10-0.14, 0.11- 0.14, 0.12-0.14, or 0.13-0.14 cm 3 /g.
  • the pore volume per aerogel mass can be about 0.055-0.065, 0.058- 0.065, 0.060-0.065, 0.055-0.063, 0.058-0.063, or 0.060-0.063 cm 3 /g.
  • the pore volume per aerogel mass can be about 0.082-0.092, 0.085-0.092, 0.082-0.090, or 0.085-0.090 cm 3 /g.
  • a neat alpha-1 ,3- glucan aerogel in some aspects has a pore volume per aerogel mass of about 0.075 cm 3 /g.
  • the pore volume of an aerogel can be measured using any suitable method, such as that disclosed in the below Examples.
  • the foregoing pore volume/mass values can optionally characterize hybrid alpha-glucan aerogels having about 2 wt% of the listed metal oxide.
  • the specific surface area can be about 75-90, 78-90, 80-90, 75-85, 78-85, or 80-85 m 2 /g.
  • the specific surface area can be about 30-40, 35-40, 30-38, or 35-38 m 2 /g.
  • the specific surface area can be about 48-58, 50-58, 48-55, or 50-55 m 2 /g.
  • a neat alpha-1 ,3-glucan aerogel in some aspects has a specific surface area of about 44.7 m 2 /g.
  • the specific surface area of a porous material such as an aerogel herein refers to the interstitial surface area of the voids and/or pores per unit mass of the porous material.
  • the specific surface area of an aerogel can be measured using any suitable method, such as the Brunauer-Emmett-Teller (BET) measurement (e.g., per the below Examples).
  • BET Brunauer-Emmett-Teller
  • the specific surface area values can optionally characterize hybrid alphaglucan aerogels having about 2 wt% of the listed metal oxide.
  • a composition/product comprises an aerogel that has been comminuted (i.e., particulated).
  • An aerogel can optionally be provided in the form of a powder or other particulate form (e.g., grains, dust, granules, flakes).
  • a method of producing an aerogel herein can optional further comprise a step of comminuting the aerogel, for example, such as by grinding, pulverizing, shaving, chopping, cutting, or other action that serves to comminute a solid).
  • Aerogel particles in some aspects can be about , or at least about, 5, 10, 25, 50, 75, 100, 125, 150, 200, 300, 400, 500, 600, 700, 800, 900, 1000, 5-125, 5-250, 5-500, 5-1000, 50-125, 50-250, 50-500, 50-1000, IGO- 125, 100-250, 100-500, or 100-1000 micrometers in diameter or longest dimension.
  • biodegradability can be, for example, as determined by the Carbon Dioxide Evolution Test Method (OECD Guideline 301 B, incorporated herein by reference), to be about, at least about, or at most about, 5%, 10%, 15%, 20%, 25%, 30%, 35%, 40%, 45%, 50%, 55%, 60%, 65%, 70%, 75%, 80%, 85%, 90%, 5-60%, 5- 80%, 5-90%, 40-70%, 50-70%, 60-70%, 40-75%, 50-75%, 60-75%, 70-75%, 40-80%, 50-80%, 60-80%, 70-80%, 40-85%, 50-85%, 60-85%, 70-85%, 40-90%, 50-90%, 60- 90%, or 70-90%, or any value between 5% and 90%, after 15, 30, 45, 60, 75, or 90 days of testing.
  • an aerogel is heat-resistant in some aspects.
  • an aerogel can withstand degrading when exposed to a temperature of about, or up to about, 210, 225, 250, 275, 300, 325, 350, 210-250, 225-250, 210-300, or 225-300 °C.
  • Such heatresistance can regard an aerogel comprising about 1 , 1.5, 2, 2.5, 3, 4, 1-4, 1-3, or 1.5- 2.5 wt% of a metal oxide herein, for example; other metal oxide content levels disclosed herein are also contemplated.
  • Heat degradation can be manifest as a loss in weight (e.g., of about, or at least about, 50, 60, 70, 80, or 90%) upon being exposed to a foregoing temperature for a period of about 0.5, 1 , 2, 5, 10, 15, 30, or 60 minutes, for example.
  • Heat degradation resistance of an aerogel herein can be measured using any suitable method such as, for example, the methodology disclosed in the below Examples.
  • a hydrogel or aerogel comprises water-insoluble alpha-glucan herein that has been crosslinked using one or more crosslinking agents.
  • crosslinking agents herein include phosphoryl chloride (POCh), polyphosphate, sodium trimetaphosphate (STMP), boron-containing compounds (e.g., boric acid, diborates, tetraborates such as tetraborate decahydrate, pentaborates, polymeric compounds such as Polybor®, alkali borates), polyvalent metals (e.g., titanium-containing compounds such as titanium ammonium lactate, titanium triethanolamine, titanium acetylacetonate, or polyhydroxy complexes of titanium; zirconium-containing compounds such as zirconium lactate, zirconium carbonate, zirconium acetylacetonate, zirconium triethanolamine, zirconium diisopropylamine lactate, or polyhydroxy complexes of zirconium), glyoxal, gluta
  • crosslinking agents typically can dissolve in an aqueous caustic solvent herein and act to crosslink alphaglucan molecules that are also dissolved in the caustic solvent.
  • crosslinking typically is covalent; i.e. , alpha-glucan molecules are chemically crosslinked with each other (via intermolecular crosslinks).
  • an aerogel of the present disclosure typically can absorb water or another aqueous liquid.
  • an aerogel can further comprise water or another aqueous liquid, where such water or aqueous liquid was absorbed by the aerogel (e.g., such as would be produced when a product comprising the aerogel is used in a method herein of absorbing an aqueous liquid).
  • such an aerogel is under an applied load (e.g., as below) (e.g., under compression).
  • An aqueous liquid in some aspects comprises an aqueous solution, such as a salt solution (saline solution).
  • a salt solution can optionally comprise about, or at least about, .01 , .025, .05, .075, .1 , .25, .5, .75, .9, 1.0, 1.25, 1.5, 1.75, 2.0, 2.5, 3.0, .5-1.5, .5-1.25, .5-1 .0, .75-1.5, .75-1.25, or .75-1 .0 wt% of salt (such wt% values typically refer to the total concentration of one or more salts).
  • Examples of a salt that can be used in an aqueous solution herein include one or more sodium salts (e.g., NaCI, Na 2 SO4).
  • Other examples of salts include those having (i) an aluminum, ammonium, barium, calcium, chromium (II or III), copper (I or II), iron (II or III), hydrogen, lead (II), lithium, magnesium, manganese (II or III), mercury (I or II), potassium, silver, sodium strontium, tin (II or IV), or zinc cation, and (ii) an acetate, borate, bromate, bromide, carbonate, chlorate, chloride, chlorite, chromate, cyanamide, cyanide, dichromate, dihydrogen phosphate, ferricyanide, ferrocyanide, fluoride, hydrogen carbonate, hydrogen phosphate, hydrogen sulfate, hydrogen sulfide, hydrogen sulfite, hydride, hydroxide, hypochlorite, io
  • An aqueous liquid that can be absorbed by an aerogel herein can have a viscosity of about, at least about, or less than about, 1 , 5, 10, 15, 20, 25, 50, 75, 100, 125, 1-125, 1-100, 1-50, 1-25, 1-15, 1-10, 1-5, 5-125, 5-100, 5-50, 5-15, 5-25, or 5-10 centipoise (cps, cP), for example.
  • the viscosity of an aqueous liquid herein can be as measured at any temperature between about 3 °C to about 80 °C, for example (e.g., 4-30 °C, 15-30 °C, 15-25 °C), or any particular temperature disclosed herein for an aqueous composition.
  • Viscosity typically is as measured at atmospheric pressure (about 760 torr) or a pressure that is ⁇ 10% thereof. Viscosity can be measured using a viscometer or rheometer, for example, and can optionally be as measured at a shear rate (rotational shear rate) of about 0.1 , 0.3, 0.5, 1.0, 3, 5, 10, 50, 100, 200, 500, 0.1-500, 0.1-100, 1.0- 500, or 1.0-100 S’ 1 (1/s), or about 5, 10, 20, 25, 50, 100, 200, or 250 rpm (revolutions per minute), for example.
  • a shear rate rotational shear rate
  • An aqueous liquid that can be absorbed by an aerogel herein can be at a temperature of about 3 °C to about 80 °C, for example (e.g., 20, 25, 30, 35, 37, 40, 45, 4- 30, 15-30, 15-25 °C, 30-45, 30-40, 35-45, or 35-40 °C).
  • An aqueous liquid that can be absorbed by an aerogel herein can be a bodily fluid, urine, blood, blood serum, menstrual fluid, liquid fecal matter (e.g., diarrhea), bile, stomach acid/juice, vomit, amniotic fluid, breast milk, cerebrospinal fluid, exudate, lymph, mucus (e.g., nasal drainage, phlegm), peritoneal fluid, pleural fluid, pus, rheum, saliva, sputum, synovial fluid, sweat, tears, water, or saline, for example.
  • liquid fecal matter e.g., diarrhea
  • bile e.g., stomach acid/juice
  • vomit amniotic fluid
  • breast milk e.g., cerebrospinal fluid
  • exudate e.g., lymph, mucus (e.g., nasal drainage, phlegm), peritoneal fluid, pleural fluid, pus, rheum,
  • Absorption of an aqueous liquid herein can be gauged by measuring the water retention value (WRV) (or other like terms, such as water retention capacity or water uptake) of the aerogel, for example.
  • WRV herein can be measured by any suitable means, such as via the methodology disclosed in U.S. Patent Appl. Publ. No. 2016/0175811 (e.g., Example 7 therein), which is incorporated herein by reference, or by any methodology disclosed in the below Examples. Briefly, the WRV of a material such as an aerogel herein can be calculated using the following formula: ((mass of wet material - mass of dry material) I mass of dry material) * 100. WRV can be measured with respect to any aqueous liquid as presently disclosed, for example.
  • WRV contains the word “water”, it would be understood that WRV can be measured with regard to any type of aqueous liquid disclosed herein, such as an aqueous solution or a bodily fluid.
  • Absorption of an aqueous liquid by an aerogel herein can optionally be gauged by measuring centrifugal retention capacity (CRC) as disclosed in the below Examples or in U.S. Patent. No. 8859758 (incorporated herein by reference), for example.
  • Absorption herein can optionally be measured by determining absorption under load (AUL), such as via the methodology disclosed in U.S. Patent. No. 8859758 or EDANA (European Disposables and Non-woven Association) standard test WSP 242.2.
  • AUL absorption under load
  • An applied load herein can be a pressure that is above atmospheric pressure (i.e., above ⁇ 15 pounds-per-square-inch [psi]), and/or can be about, or at least about, 50, 75, 100, 125, 150, 200, 250, 500, 1000, 2500, 5000, 75-150, or 75-125 g, for example (e.g., pressure/weight as applied to an area of aerogel of about, or under about, 2, 4, 6, 8, 10, or 12 cm 2 ).
  • An aerogel herein can have a WRV of about, or at least about, 1000, 1100, 1200, 1300, 1400, 1500, 1600, 1700, 1800, 1900, 2000, 2100, 2200, 2300, 2400, 2500, 1000- 2500, 1200-2500, 1300-2500, 1400-2500, 1500-2500, 1800-2500, 1000-2200, 1200- 2200, 1300-2200, 1400-2200, 1500-2200, 1800-2200, 1000-2000, 1200-2000, 1300- 2000, 1400-2000, 1500-2000, or 1800-2000, for example. Any of these values can be with respect to WRV measured without an applied load, or under an applied load (e.g., as above).
  • any of the foregoing WRV values can be with respect to an aerogel that has been exposed (with or without an applied load) to an aqueous liquid (i.e., time to absorb) for a time of about, or at least about, 20, 30, 40, 50, 60, 70, 80, 90, 100, 110, 120, 60- 120, 60-110, 60-100, 80-120, 80-110, or 80-100 seconds, for example.
  • a composition/product comprising an aerogel as presently disclosed can be in the form of, or comprised within, a personal care product, household care product (household product), medical product, pharmaceutical product, or industrial product, for example.
  • a composition/product herein e.g., any of the foregoing
  • a personal care product, household care product, medical product, pharmaceutical product, or industrial product in some aspects is optionally designed, at least in part, for handling aqueous liquid absorption.
  • Examples of personal care products and/or uses thereof in aqueous liquid absorption include absorbent personal hygiene products such as baby diapers, potty training pants/liners, incontinence products (e.g., pads, adult diapers), and feminine hygiene products (e.g., sanitary napkins/pads, tampons, interlabial products, panty liners).
  • a personal care product in some aspects can be characterized as a personal care absorbent article that can be placed against or near the skin to absorb and contain a fluid discharged or emitted from the body.
  • Examples of personal care products that can be adapted accordingly to take advantage of the absorbency of an aerogel material herein are disclosed in W01999/037261 , U.S. Patent Appl. Publ. Nos. 2004/0167491 , 2009/0204091 , 2001/0014797, 2013/0281949, 2002/0087138, 2010/0241098, 2011/0137277 and 2007/0287971 , and U.S. Patent Nos.
  • Examples of industrial products and/or uses thereof in aqueous liquid absorption include cable wrappings (e.g., wrappings for power or telecommunication cables); food pads (e.g., meat pads); agricultural and forestry applications such as for retaining water in soil and/or to release water to plant roots; fire-fighting devices; and cleanup of acidic or basic aqueous solutions spills.
  • Examples of industrial products that can be adapted accordingly to take advantage of the absorbency of an aerogel material herein are disclosed in U.S. Patent Appl. Publ. Nos. 2002/0147483, 2006/0172048, 20050008737, 2008/0199577, 2012/0328723 and 2004/0074271 , and U.S. Patent Nos.
  • Examples of medical products and/or uses thereof in aqueous liquid absorption include wound healing dressings such as bandages and surgical pads; hospital bedding; sanitary towels/pads; controlled drug release devices; cell immobilization islets; three- dimensional cell culture substrates; bioactive scaffolds for regenerative medicine; stomach bulking devices; and disposal of controlled drugs.
  • wound healing dressings such as bandages and surgical pads; hospital bedding; sanitary towels/pads; controlled drug release devices; cell immobilization islets; three- dimensional cell culture substrates; bioactive scaffolds for regenerative medicine; stomach bulking devices; and disposal of controlled drugs.
  • Examples of medical products that can be adapted accordingly to take advantage of the absorbency of an aerogel material herein are disclosed in WO1998/046159, U.S. Patent Appl. Publ. Nos. 2005/0256486, 20030070232 and 20040128764, and U.S. Patent Nos. 6191341 , 7732657, 4925453, 9161860, 3187747 and 5701617, all of
  • An absorption method comprises, at least, contacting a composition/product comprising an aerogel herein with an aqueous liquid-comprising composition, wherein the composition/product absorbs aqueous liquid from the liquidcomprising composition.
  • An aqueous liquid-comprising composition can be any aqueous liquid disclosed herein, for example.
  • an aerogel can further comprise water or an aqueous liquid (e.g., as disclosed herein); typically, the water or aqueous liquid has been absorbed by the aerogel.
  • An aerogel that has absorbed water can either be under a load or no load, for instance.
  • the amount of water or aqueous liquid comprised in an aerogel herein can be up to the amount (or range) that reflects the water absorption capacity (e.g., as disclosed herein) of the aerogel, for example.
  • a caustic solution (an aqueous caustic solution) comprising at least (i) an aqueous caustic solvent, (ii) a water-insoluble alpha-glucan, and (iii) a metal hydroxide, wherein at least about 50% of the glycosidic linkages of the water-insoluble alpha-glucan are alpha-1 ,3 glycosidic linkages, wherein the water-insoluble alpha-glucan is dissolved in the aqueous caustic solvent and the metal hydroxide is not dissolved in (i.e.
  • the metal hydroxide is calcium hydroxide [Ca(OH) 2 ], magnesium hydroxide [Mg(OH) 2 ], or titanium hydroxide [Ti(OH) 4 ] (or any other hydroxide of an alkali earth metal or transition metal, which metal hydroxide is suitable for producing a hydrogel of alpha-1 ,3-glucan using an aqueous caustic solution herein).
  • the water-insoluble alphaglucan component of a caustic solution herein can be as presently disclosed; for example, it can have a molecular weight (e.g., DP, DPw, or DPn) and/or glycosidic linkage profile as disclosed herein for an water-insoluble alpha-glucan.
  • a molecular weight e.g., DP, DPw, or DPn
  • glycosidic linkage profile as disclosed herein for an water-insoluble alpha-glucan.
  • a metal hydroxide in some aspects can be calcium hydroxide [Ca(OH) 2 ], magnesium hydroxide [Mg(OH) 2 ], or titanium hydroxide [Ti(OH) 4 ]. It is contemplated that a metal hydroxide herein can be another type of alkali earth metal hydroxide or transition metal hydroxide, for example, which metal hydroxide is suitable for forming a hydrogel using an aqueous caustic solution herein.
  • an aqueous caustic solution or hydrogel herein has one metal hydroxide, but in some cases it can have two or more metal hydroxides [e.g., Ca(OH) 2 and Mg(OH) 2 , Ca(OH) 2 and Ti(OH) 4 , Mg(OH) 2 and Ti(OH) 4 ],
  • a metal hydroxide herein, as comprised in an aqueous caustic solution herein typically is not dissolved in (i.e., it is insoluble in) the caustic solvent; thus, an aqueous caustic solution herein can also optionally be characterized as an “aqueous caustic liquid composition” or other like terms.
  • An insoluble metal hydroxide of an aqueous caustic solution can be provided therein by adding a corresponding salt (salt precursor of the metal hydroxide) to the caustic solution of the disclosure.
  • a corresponding salt salt precursor of the metal hydroxide
  • MgCI 2 .6H 2 O, CaCI 2 .2H 2 O, or Ti[OCH(CH 3 )2] 4 inorganic salt can be added to provide insoluble Mg(OH) 2 , Ca(OH) 2 , or Ti(OH) 4 ; these hydroxides precipitate (become undissolved) given the elevated pH of the solution.
  • a salt, to be added to an aqueous caustic solution can be provided as an aqueous solution of the salt, for example.
  • undissolved metal hydroxide can be provided in an aqueous caustic solution herein before introduction of insoluble alpha-glucan thereto.
  • An aqueous caustic solution or hydrogel herein can comprise an amount of metal hydroxide that is sufficient to provide an aerogel comprising a given amount of corresponding metal oxide (e.g., as disclosed herein) following the removal of water from a hydrogel (when producing the aerogel).
  • the balance of the mass of an aqueous caustic solution or hydrogel is of (i) water-insoluble alpha-glucan and (ii) water or aqueous solution (i.e.
  • an aqueous caustic solution or hydrogel can be characterized as consisting of metal hydroxide, water-insoluble alpha-glucan, and water/aqueous solution) (when referring to a caustic aqueous solution, it typically further includes an alkali hydroxide [e.g., an alkali metal hydroxide such as NaOH, KOH, or LiOH]).
  • an aqueous caustic solution or hydrogel can comprise one or more other components.
  • An aqueous caustic solution or hydrogel can comprise about, or at least about, 3, 5, 6, 7, 8, 9, 10, 12, 14, 3-9, 4-8, or 5-7 wt% of water-insoluble alpha-glucan, in some aspects.
  • An aqueous caustic solution or hydrogel in some aspects does not comprise polyurethane or any other organic polymer (aside for the insoluble alpha-glucan), and/or does not comprise silica. It is noted that an aqueous caustic solution of the foregoing disclosure can be that which is provided when performing a method herein of producing an aerogel or hydrogel.
  • An aqueous caustic solvent herein typically can dissolve an aqueous-insoluble alpha-glucan as presently disclosed.
  • An aqueous caustic solvent can comprise an alkali hydroxide, for example.
  • An alkali hydroxide can comprise at least one metal hydroxide (e.g., NaOH, KOH, LiOH) or organic hydroxide (e.g., tetraethyl ammonium hydroxide).
  • An aqueous caustic solvent can be as disclosed, for example, in Int. Pat. Appl. Publ. Nos. W02015/200612 or WO2015/200590, or U.S. Pat. Appl. Publ. Nos. 2017/0208823 or 2017/0204203, which are each incorporated herein by reference, or as disclosed in the below Examples.
  • an aqueous caustic solvent comprises one or more alkali hydroxides dissolved in water.
  • concentration of the alkali hydroxide(s) can be about, or at least about, 2.5, 2.6, 2.7, 2.75, 2.8, 2.9, 3, 4, 5, 6, 7, 2.5-4, 2.5-3, 2.5-2.8, 2.6-4, 2.6-3, 2.6-2.8, 2.7-4, 2.7-3, 2.7-2.8, 3-5, or 3-4 wt%, for example.
  • the pH of an aqueous caustic solution herein and/or its aqueous caustic solvent can be about, or at least about, 11.0, 11.5, 12.0, 12.5, 12.75, 13.0, 13.25, 13.5, 13.75, 12.0-13.5, 12.0-13.0, 12.5-13.75, 12.5-13.5, 12.5-13.25, 12.5-13.0, 12.75-13.75, 12.75- 13.5, 12.75-13.25, 12.75-13.0, 13.0-13.75, 13.0-13.5, 13.0-13.25, 13.25-13.75, or 13.25- 13.5, for example.
  • Such a pH can characterize an aqueous caustic solution before addition of an acid in some aspects.
  • such a pH can characterize an aqueous caustic solution after addition of an acid (e.g., for partial neutralization, where the pH is lowered to be closer to neutral, but not completely neutral).
  • the temperature of an aqueous caustic solution herein can be about, or at least about, 1 , 5, 10, 15, 20, 25, 30, 35, 40, 45, 50, 1-50, 1-45, 1-40, 1-35, 1-30, 1-25, 1-20, 15-50, 15-45, 15-40, 15-35, 15-30, 15-25, 15-20, 20-50, 20-45, 20-40, 20-35, 20-30, 20-25, 5-30, IQ- 30, 5-25, or 10-25 °C, for example.
  • Some aspects of the present disclosure concern a method/process of producing a hydrogel or an aerogel, such as disclosed herein.
  • Such a method can comprise at least:
  • An aerogel or hydrogel herein can be as produced by an aerogel/hydrogel production method as presently disclosed, for example.
  • a salt can be added to an aqueous caustic solution before alpha-glucan has been added to the solution.
  • the metal hydroxide precipitates (becomes undissolved) upon its corresponding salt being mixed into the elevated pH of an aqueous caustic solution.
  • the amount of salt provided can be that which provides a metal hydroxide content as disclosed elsewhere herein, for example.
  • Step (b) of an aerogel/hydrogel production method herein i.e., putting the aqueous caustic solution into a desired form
  • Step (b) of an aerogel/hydrogel production method herein i.e., putting the aqueous caustic solution into a desired form
  • Step (b) of an aerogel/hydrogel production method herein can comprise, for example, placing/pouring the aqueous caustic solution of step (a) into a form that has the shape desired for the aerogel/hydrogel product.
  • An aerogel or hydrogel product herein can be any of the foregoing shapes, for example.
  • an aerogel or hydrogel shape can be that which is cut out from a larger aerogel or hydrogel. While step (b) can be performed before step (c) of an aerogel/hydrogel production method herein, step (b) can optionally be performed at about the same time as, or shortly after commencing, step (c), but before hydrogel formation (see below disclosure).
  • Step (c) of an aerogel/hydrogel production method herein can comprise chemically or ionically modifying the aqueous caustic solvent (chemically or ionically modifying the aqueous caustic solution) such that the water-insoluble alpha-glucan and the metal hydroxide are undissolved in (i.e., are insoluble in) the solvent (i.e., the alphaglucan comes out of solution; the metal hydroxide was already out of the solution per step [a]), whereby a hydrogel is produced.
  • chemically or ionically modifying the aqueous caustic solvent chemically or ionically modifying the aqueous caustic solution
  • step (c) typically comprises reducing the pH of the aqueous caustic solution to a pH that renders the water-insoluble alpha-glucan to be undissolved in the solvent.
  • step (c) is used to allow the form/shape produced in step (b) to be free-standing.
  • Step (c) in some aspects can be performed by mixing one or more acids into the aqueous caustic solution, such as a weak acid (e.g., acetic acid, citric acid) or a strong acid (e.g., sulfuric acid).
  • a weak acid e.g., acetic acid, citric acid
  • a strong acid e.g., sulfuric acid
  • the amount of acid added would result in an acid concentration of about 0.008, 0.010, 0.012, 0.0125, 0.013, 0.014, 0.015, 0.020, 0.025, 0.030, 0.040, 0.050, 0.075, 0.10, 0.25, 0.50, 1 , 2.5, 5, 0.008-0.020, 0.008-0.015, 0.010- 0.020, 0.010-0.015, or 0.01-0.014 wt% (where such wt% would occur if the acid was not consumed during the ensuing neutralization).
  • the pH resulting from performing neutralization such as a partial neutralization can be any of those pH values/ranges as listed above for an aqueous caustic solution, for example.
  • the pH reduction is by no more than 0.25, 0.3, 0.35, 0.4, 0.45, or 0.5.
  • the temperature at which step (c) is conducted can be any temperature as listed above for an aqueous caustic solution, for example.
  • the amount of time for neutralization or partial neutralization to occur can be for about, or at least about, 2, 3, 6, 12, 24, 36, 48, 60, 72, 84, or 96 hours, for example.
  • step (b) can optionally be performed simultaneously with, or shortly after commencing step (c), but before the hydrogel forms. For example, within a short time (e.g., about 1 , 2, 5, 10, 15, or 20 minutes) of mixing a neutralizing agent such as acid into the solution, the solution can be placed into a desired form.
  • coagulation and/or neutralization in step (c) can be performed as described in U.S. Patent Appl. Publ. No.
  • a hydrogel formed in step (c) typically can be isolated.
  • a hydrogel can be washed, such as with water or a suitable polar organic solvent (e.g., alcohol such as ethanol) (with or without added water). If desired, washing can be done until a neutral pH (e.g., pH 6-8, or ⁇ 7) (of the wash) is achieved. Washing, or a post-washing step, can optionally further include bathing the hydrogel in a 1-10 wt% (e.g., ⁇ 5 wt%) plasticizer (e.g., glycerol or ethylene glycol) solution (e.g., water- or alcohol-based) for a suitable period of time (e.g., at least 2, 3, or 4 minutes).
  • a suitable polar organic solvent e.g., alcohol such as ethanol
  • washing can be done until a neutral pH (e.g., pH 6-8, or ⁇ 7) (of the wash) is achieved.
  • a hydrogel can optionally be stored in water or a suitable polar organic solvent solution (e.g., alcohol such as ethanol) (with or without added water). While a “hydrogel” containing liquid that has no water technically is not a hydrogel per the above definition, such a composition is referred to as a “hydrogel” herein for ease of reference.
  • a suitable polar organic solvent solution e.g., alcohol such as ethanol
  • Step (d) of the foregoing production method can be performed if an aerogel is desired (to be made using the hydrogel product of step [c]).
  • Step (d) can comprise removing all of, or most of (e.g., at least 97%, 98%, 99%, 99.5%, or 99.9% by weight of) the residing liquid (typically water and/or any other suitable liquid such as a polar organic solvent, with or without added water) from the hydrogel, thereby producing an aerogel.
  • Removal of residing liquid from a hydrogel can be performed, for example, in such a way that the structure of the hydrogel is not substantially changed/altered.
  • residing liquid can be removed in a manner that substantially preserves the nano- and/or micro-structure (structure as observed on a nanometer or micrometer scale, respectively) of the hydrogel as it existed before removal of residing liquid therefrom.
  • Substantial preservation of hydrogel structure in some aspects can be with respect to average pore size.
  • the average pore diameter of an aerogel from which residing liquid has been removed can be within ( ⁇ ) about 15%, 14%, 13%, 12%, 11%, 10%, 9%, 8%, 7%, 6%, 5%, 4%, 3%, 2%, or 1% of the average pore diameter as it had existed before removing the residing liquid (i.e. , when it was a hydrogel).
  • Average pore diameter can be measured as disclosed herein, for example.
  • Freeze-drying and supercritical drying are examples of means herein for removing residing liquid from a hydrogel to produce an aerogel.
  • Standard air drying means such as oven drying typically are not used herein for removing residing liquid from a hydrogel. Freeze-drying herein can be performed following the procedure listed in the disclosed Examples, for instance.
  • freeze-drying can be performed at a temperature of about -120, -110, -105, -100, -90, -80, -70, -60, -50, -40, -80 to -120, -80 to -110, -90 to -120, -90 to -110, or -100 to -110 °C, and/or for a time of about, or at least about, 1 , 2, 6, 12, 24, 36, 48, 60, 72, or 84 hours under applied vacuum.
  • a vacuum can be applied such that the pressure is less than about 400, 300, 200, 100, or 50 mTorr, for example; vacuum pressure can be at about 150-250, 175-225, or about 200 mTorr in some aspects.
  • a hydrogel can first be normally frozen (e.g., about -20 °C at atmospheric pressure) before entry to freeze-drying processing.
  • Supercritical drying can be performed using supercritical CO2 (supercritical CO2 drying), for example, such as disclosed in Int. Pat. Appl. Publ. No. WO2019/167013, or U.S. Pat. Appl. Publ. Nos. 2016/0058045, 2016/0068650, or 20130018112, which are incorporated herein by reference.
  • a composition/product comprising an aerogel or hydrogel as presently disclosed can be in the form of a household care product, personal care product, industrial product, medical product, or pharmaceutical product, for example, such as described in any of U.S. Pat. Appl. Publ. Nos. 2018/0022834, 2018/0237816, 2018/0230241 , 20180079832, 2016/0311935, 2016/0304629, 2015/0232785, 2015/0368594, 2015/0368595, 2016/0122445, 2019/0202942, or 2019/0309096, or Int. Pat. Appl. Publ. No. WO201 6/133734, which are all incorporated herein by reference.
  • composition/product comprising an aerogel or hydrogel herein can comprise at least one component/ingredient of a household care product, personal care product, industrial product, medical product, or pharmaceutical product as disclosed in any of the foregoing publications and/or as presently disclosed.
  • compositions and methods disclosed herein include:
  • a composition (product) comprising at least an aerogel (or foam/solid foam, or sponge/solid sponge), wherein the aerogel comprises at least a water-insoluble alphaglucan and a metal oxide, wherein at least about 50% of the glycosidic linkages of the insoluble alpha-glucan are alpha-1 ,3 linkages, and wherein the metal oxide is calcium oxide (CaO), magnesium oxide (MgO), or titanium dioxide (TO2) (or any other suitable oxide of an alkali earth metal or transition metal).
  • the aerogel or foam/solid foam, or sponge/solid sponge
  • the aerogel comprises at least a water-insoluble alphaglucan and a metal oxide, wherein at least about 50% of the glycosidic linkages of the insoluble alpha-glucan are alpha-1 ,3 linkages, and wherein the metal oxide is calcium oxide (CaO), magnesium oxide (MgO), or titanium dioxide (TO2) (or any other suitable oxide of an alkali earth metal or transition metal).
  • composition of embodiment 1 wherein at least about 90% of the glycosidic linkages of the water-insoluble alpha-glucan are alpha-1 ,3 glycosidic linkages.
  • composition of embodiment 1 or 2, wherein the water-insoluble alpha-glucan has a weight-average degree of polymerization (DPw) of at least about 10.
  • composition of embodiment 1 , 2, 3, 4, 5, 6, or 7, wherein the aerogel has been comminuted e.g., comminuted to particles such as of a powder) (i.e., particulated).
  • an absorbent product e.g., a personal care product, household care product, medical product, pharmaceutical product, or industrial product that can absorb an aqueous liquid.
  • a caustic solution (an aqueous caustic solution) comprising at least (i) an aqueous caustic solvent, (ii) a water-insoluble alpha-glucan, and (iii) a metal hydroxide, wherein at least about 50% of the glycosidic linkages of the water-insoluble alpha-glucan are alpha-1 ,3 glycosidic linkages, wherein the water-insoluble alpha-glucan is dissolved in the aqueous caustic solvent and the metal hydroxide is not dissolved in (i.e.
  • the metal hydroxide is calcium hydroxide, magnesium hydroxide, or titanium hydroxide (or any other hydroxide of an alkali earth metal or transition metal, where such hydroxide is insoluble in the aqueous caustic solvent).
  • aqueous caustic solvent comprises at least one alkali hydroxide (e.g., an alkali metal hydroxide such as NaOH, KOH, or LiOH).
  • alkali hydroxide e.g., an alkali metal hydroxide such as NaOH, KOH, or LiOH.
  • a method/process of producing an aerogel comprising: (a) providing a caustic solution (aqueous caustic solution) according to embodiment 11 , 12, 13, or 14, (b) putting the caustic solution into a desired form, (c) chemically or ionically modifying the aqueous caustic solvent (chemically or ionically modifying the caustic solution) such that the waterinsoluble alpha-glucan and the metal hydroxide are undissolved in (i.e., are insoluble in) the solvent, whereby a hydrogel is produced (optionally, step [c] can be performed before or simultaneously to performing step [b]), and (d) removing all of the water, or most of the water (e.g., at least 98%, 99%, 99.5%, or 99.9% by weight of the water), from the hydrogel, whereby an aerogel is produced.
  • step (a) comprises combining (mixing, introducing) a salt of the metal hydroxide (salt precursor of the metal hydroxide) with an aqueous caustic solution in which the water-insoluble alpha-glucan is dissolved, typically wherein the salt is provided as dissolved in an aqueous solution, and the metal hydroxide precipitates out of solution upon being combined with the aqueous caustic solution.
  • step (c) comprises reducing the pH of the caustic solution to a pH that renders the water-insoluble alpha-glucan to be undissolved in the solvent (e.g., neutralization or partial neutralization of the solution, such as can be done by adding an acid) (in some aspects, the pH reduction is allowed to occur for a time of at least about 48 hours) (in some aspects, the pH reduction is by no more than 0.5).
  • a pH that renders the water-insoluble alpha-glucan to be undissolved in the solvent e.g., neutralization or partial neutralization of the solution, such as can be done by adding an acid
  • the pH reduction is allowed to occur for a time of at least about 48 hours
  • the pH reduction is by no more than 0.5.
  • step (c) further comprises keeping the solution still (e.g., no liquid agitation means such is/are applied) during formation of the hydrogel.
  • step (d) comprises freeze- drying or supercritical drying the hydrogel (or any other process that removes the residual water/liquid in a manner that substantially preserves the nano-structure and/or micro-structure of the hydrogel as it existed before removal of the residual water/liquid) to form the aerogel.
  • An absorption method that comprises contacting a composition/product according to embodiment 1 , 2, 3, 4, 5, 6, 7, 8, 9, 10, or 10a with an aqueous liquid-comprising composition, wherein the composition/product absorbs aqueous liquid from the aqueous liquid-comprising composition.
  • compositions and methods disclosed herein include: 1b.
  • a composition (product) comprising at least a hydrogel, wherein the hydrogel comprises at least a water-insoluble alpha-glucan and a metal hydroxide, wherein at least about 50% of the glycosidic linkages of the insoluble alpha-glucan are alpha-1 ,3 linkages, and wherein the metal hydroxide is calcium hydroxide [Ca(OH) 2 ], magnesium hydroxide [Mg(OH) 2 ], or titanium hydroxide [Ti(OH) 4 ] (or any other hydroxide of an alkali earth metal or transition metal, wherein this metal hydroxide is suitable for forming a hydrogel of the water-insoluble alpha-glucan).
  • composition of embodiment 1b wherein at least about 90% of the glycosidic linkages of the water-insoluble alpha-glucan are alpha-1 ,3 glycosidic linkages.
  • composition of embodiment 1 b or 2b, wherein the water-insoluble alphaglucan has a weight-average degree of polymerization (DPw) of at least about 10.
  • composition of embodiment 1b, 2b, 3b, 4b, 5b, 6b, or 7b, wherein the hydrogel is produced by the method of embodiment 12b, 13b, 14b, or 15b.
  • a caustic solution (an aqueous caustic solution) comprising at least (i) an aqueous caustic solvent, (ii) a water-insoluble alpha-glucan, and (iii) a metal hydroxide, wherein at least about 50% of the glycosidic linkages of the water-insoluble alpha-glucan are alpha-1 ,3 glycosidic linkages, wherein the water-insoluble alpha-glucan is dissolved in the aqueous caustic solvent and the metal hydroxide is not dissolved in (i.e.
  • the metal hydroxide is calcium hydroxide, magnesium hydroxide, or titanium hydroxide (or any other hydroxide of an alkali earth metal or transition metal, where such hydroxide is insoluble in the aqueous caustic solvent).
  • aqueous caustic solvent comprises at least one alkali hydroxide (e.g., an alkali metal hydroxide such as NaOH, KOH, or LiOH).
  • alkali hydroxide e.g., an alkali metal hydroxide such as NaOH, KOH, or LiOH.
  • a method/process of producing a hydrogel (e.g., according to embodiment 1b, 2b, 3b, 4b, 5b, 6b, or 7b), the method comprising: (a) providing a caustic solution (aqueous caustic solution) according to embodiment 8b, 9b, 10b, or 11 b, (b) putting the caustic solution into a desired form, and (c) chemically or ionically modifying the aqueous caustic solvent (chemically or ionically modifying the caustic solution) such that the waterinsoluble alpha-glucan and the metal hydroxide are undissolved in (i.e., are insoluble in) the solvent, whereby a hydrogel is produced (optionally, step [c] can be performed before or simultaneously to performing step [b]).
  • step (a) comprises combining (mixing, introducing) a salt of the metal hydroxide (salt precursor of the metal hydroxide) with an aqueous caustic solution in which the water-insoluble alpha-glucan is dissolved, typically wherein the salt is provided as dissolved in an aqueous solution, and the metal hydroxide precipitates out of solution upon being combined with the aqueous caustic solution.
  • step (a) comprises combining (mixing, introducing) a salt of the metal hydroxide (salt precursor of the metal hydroxide) with an aqueous caustic solution in which the water-insoluble alpha-glucan is dissolved, typically wherein the salt is provided as dissolved in an aqueous solution, and the metal hydroxide precipitates out of solution upon being combined with the aqueous caustic solution.
  • step (c) comprises reducing the pH of the caustic solution to a pH that renders the water-insoluble alpha-glucan to be undissolved in the solvent (e.g., neutralization or partial neutralization of the solution, such as can be done by adding an acid) (in some aspects, the pH reduction is allowed to occur for a time of at least about 48 hours) (in some aspects, the pH reduction is by no more than 0.5).
  • a pH that renders the water-insoluble alpha-glucan to be undissolved in the solvent e.g., neutralization or partial neutralization of the solution, such as can be done by adding an acid
  • the pH reduction is allowed to occur for a time of at least about 48 hours
  • the pH reduction is by no more than 0.5.
  • step (c) further comprises keeping the solution still (e.g., no liquid agitation means is/are applied) during formation of the hydrogel.
  • compositions in some alternative/auxiliary aspects include:
  • a composition (product) comprising about 35 to 65 wt% of a polyurethane, about 1 to 15 wt% of a water-insoluble alpha-glucan, and about 30 to 60 wt% of propanediol, wherein at least about 50% of the glycosidic linkages of the water-insoluble alpha-glucan are alpha-1 ,3 linkages, and typically wherein the composition is a dry solid material (the water-insoluble alpha-glucan can be as disclosed herein).
  • composition of embodiment 1 wherein the composition is an elastomeric composition.
  • composition of embodiment 1 or 2 wherein the composition is a foam.
  • composition of embodiment 1 , 2, 3, or 4 wherein at least about 90% of the glycosidic linkages of the water-insoluble alpha-glucan are alpha-1 ,3 linkages.
  • DPw weight-average degree of polymerization
  • composition of embodiment 7, wherein the DPw of the water-insoluble alphaglucan is about, or at least about, 700 or 800.
  • composition of embodiment 8, wherein the DPw of the water-insoluble alphaglucan is about, or at least about, 1400 or 1600.
  • composition of embodiment 1 , 2, 3, 4, 5, 6, 7, 8, 9, 10, or 11 wherein the composition comprises about 40 to 60 wt%, 45 to 55 wt%, or 50 wt% of the polyurethane.
  • the composition comprises about 40 to 60 wt% (e.g., about 50 wt%) of the polyurethane, about 40 to 50 wt% (e.g., about 45 wt%) of the propanediol, and about 3 to 7 wt% (e.g., about 5 wt%) of the water-insoluble alpha-glucan.
  • additive e.g., a pigment and/or abrasive
  • any suitable additive as disclosed in International Patent Appl. Publ. No. WO2022/235655 or WO2023/183280, which are each incorporated herein by reference.
  • composition of embodiment 1 2, 3, 4, 5, 6, 7, 8, 9, 10, 11 , 12, 13, 14, 15, or 16, wherein the composition is a consumer product or commercial/industrial product.
  • composition of embodiment 1 2, 3, 4, 5, 6, 7, 8, 9, 10, 11 , 12, 13, 14, 15, 16, or 17, wherein the composition is footwear (e.g., a shoe or sneaker) or a component thereof (e.g., insole).
  • footwear e.g., a shoe or sneaker
  • a component thereof e.g., insole
  • composition of embodiment 1 2, 3, 4, 5, 6, 7, 8, 9, 10, 11 , 12, 13, 14, 15, 16, or 17, wherein the composition is a bedding, furniture, automotive interior, carpet underlay, or packaging, or any other product/article that typically contains polyurethane and/or a polyurethane foam.
  • a compression set that is lower (e.g., about, or at least about, 25%, 30%, 40%, 50%, 60%, 70%, or 80% lower) than the compression set of a control composition that lacks the water-insoluble alpha-glucan (e.g., replaced with commensurate amount, wt%-wise, of propanediol
  • a tear strength that is higher (e.g., about, or at least about, 100%, 200%, 300%, or 400% higher) than the tear strength of a control composition that lacks the water-insoluble alpha-glucan (e.g., replaced with commensurate amount, wt%-wise, of propanediol) (e.g., the tear strength can
  • composition of embodiment 1 , 2, 3, 4, 5, 6, 7, 8, 9, 10, 11 , 12, 13, 14, 15, 16, 17, 18, 19, 20, or 21 wherein the composition has a tensile strength that is higher (e.g., about, or at least about, 10%, 20%, 30%, 40%, or 50% higher) than the tensile strength of a control composition that lacks the water-insoluble alpha-glucan (e.g., replaced with commensurate amount, wt%-wise, of propanediol) (e.g., the tensile strength can be about 10-14, or about 10-12, as measured using a suitable technique such as per ASTM D638, which is incorporated herein by reference).
  • a tensile strength that is higher (e.g., about, or at least about, 10%, 20%, 30%, 40%, or 50% higher) than the tensile strength of a control composition that lacks the water-insoluble alpha-glucan (e.g., replaced with commensurate amount, wt%-wise, of propane
  • Reagents Calcium chloride dihydrate (CaCl2.2H 2 O, 99%, Fisher Chemical), sodium hydroxide (NaOH, 99%, EM Science), magnesium chloride hexahydrate (MgCl2.6H 2 O 99%, Sigma-Aldrich), titanium isopropoxide (Ti[OCH(CH 3 )2]4, 99%, Sigma- Aldrich), acetic acid (99%, Sigma-Aldrich), sodium hydroxide (NaOH, 99%, EM Science) and absolute ethanol (78%, Sigma-Aldrich) were obtained from the respective suppliers and used without further preparation for their respective solution preparation. Deionized water collected from Milli-DI® a water purification system was used throughout this work.
  • Alpha-1 , 3-Glucan with -100% alpha-1 ,3 glycosidic linkages can be synthesized, for example, following the procedures disclosed in U.S. Appl. Publ. No. 2014/0179913 (see Example 12 therein, for example), which is incorporated herein by reference.
  • a slurry of alpha-1 , 3-glucan with -100% alpha-1 ,3 glycosidic linkages was prepared from an aqueous solution (0.5 L) containing Streptococcus salivarius gtfJ enzyme (100 unit/L) as described in U.S. Patent Appl. Publ. No. 2013/0244288 (incorporated herein by reference), sucrose (100 g/L), potassium phosphate buffer (10 mM), and FermaSure® antimicrobial agent (100 ppm) adjusted to pH 5.5.
  • the resulting enzyme reaction was maintained at 20-25 °C for 24 hours.
  • a slurry was formed since the alpha-1 , 3-glucan synthesized in the reaction was aqueous- insoluble.
  • the alpha-1 , 3-glucan solids were then collected using a Buchner funnel fitted with a 325-mesh screen over 40-micrometer filter paper.
  • the weight average degree of polymerization (DPw) of alpha-1 , 3-glucan used in this study was about 800.
  • Hybrid Alpha-1 , 3-Glucan Hydrogel and Aerogel Preparation Preparation of freestanding hybrid alpha-1 , 3-glucan hydrogels was performed using an acid-assisted coprecipitation method. Briefly, 0.6 g of alpha-1 , 3-glucan particles was dispersed in 10 mL of deionized water for 2 minutes, followed by the addition of 1 mL of 8 M NaOH solution. This preparation was kept under continuous stirring for 10 minutes until a clear solution was obtained; the pH of this solution (stock solution) was >13.35.
  • MgCl2.6H 2 O, CaCl2.2H 2 O and Ti[OCH(CH 3 )2]4 were used, respectively, as precursors for in situ generation of the metal hydroxides Mg(OH) 2 , Ca(OH) 2 and Ti(OH) 4 .
  • MgCl2.6H 2 O and CaCl2.2H 2 O solutions were prepared by dissolving a specific amount of the salts in deionized water, before the alpha-1 , 3-glucan stock solution was added.
  • Ti(OH) 4 formation a specific amount of Ti[OCH(CH 3 )2]4 was hydrolyzed in ethanol before the alpha-1 , 3-glucan stock solution was added.
  • Alpha-1 , 3-glucan hydrogels with different amounts of the metal hydroxides were produced, and a pure alpha-1 , 3-glucan control hydrogel (neat hydrogel) (no inorganic salt used) was also prepared for comparison.
  • the hydrogels were thoroughly washed by soaking in deionized water until each hydrogel had a neutral pH. The hydrogels were then frozen at -20 °C for 4 hours followed by freeze-drying at -105 °C for 72 hours to obtain the final aerogels.
  • Hybrid glucan aerogels with different levels of metal oxide were prepared (e.g., about 2 or 10 wt%); unless otherwise disclosed, hybrid glucan aerogels as studied below contained about 2 wt% of a metal oxide.
  • Hydrogel strength measurement versus time was performed using a stress-controlled rotational rheometer (Anton Paar MCR-302) with a cone/plate geometry. Storage (G') and elastic (G") moduli were measured at a freguency of 1 Hz, temperature of 25 °C, and 1.58% strain (y) value, within a linear viscoelastic envelope. A gap size of 1 mm was used to perform oscillatory strain sweep measurements at 25 °C. A solvent-protecting cover was used to avoid dehydration of hydrogel samples during measurement. The same instrumental set up was used for examining the compressive strength of aerogels in dry form and after absorbing water.
  • cylindrical aerogels of similar height ( ⁇ 20 mm) and diameter ( ⁇ 16 mm) were used for compressive strength testing at a speed of 5 mm/min.
  • the experiment was conducted by adding 10 mL of DI water into a cylindrical tube containing an aerogel of known weight. After 100 s, which is expected to be the maximum immersion time in this study for the aerogels to be saturated with water, the aerogel was removed from the water, excess water around its walls was dried-off with paper, and the rheological test was then performed.
  • each sample was measured using a well-calibrated weighing balance with a readability of 0.0001 g, and the diameter and height were determined using an electronic digital caliper. Molders were used to prepare each hydrogel and aerogel sample to have a cylindrical shape for density measurement.
  • CLSM Confocal Laser Scanning Microscopy
  • SEM Scanning Electron Microscopy
  • D - - - - - (Eq. 4), where k is the shape factor (0.9), A is the X- hkl Cos9 hkl ray wavelength (0.154 nm), hkl is the full width at half maximum (FWHM), and Qhkl is Bragg’s angle.
  • FTIR Fourier Transform Infrared Spectroscopy
  • Nitrogen Porosity Measurement Nitrogen adsorption-desorption measurements were performed in an instrument (GERMINI VII, Micromeritics) at of 77 K. Prior to the data collection, the aerogels were pretreated, and the instrument was degassed at 120 °C for 2 hours to remove any form of adsorbed moisture. The Brunauer-Emmett-Teller (BET) and Barrett-Joyner-Halenda (BJH) methods were used to estimate the specific surface area and pore volume of each sample.
  • BET Brunauer-Emmett-Teller
  • BJH Barrett-Joyner-Halenda
  • TGA Thermogravimetric Analysis
  • XPS X-Ray Photoelectron Spectroscopy
  • Fluid Uptake and Retention Measurement Three different model fluids were used to investigate the fluid uptake capacity of aerogels: DI water as a baseline, saline water as a model for urine, and glycerol/water as a model for menstrual fluid.
  • the centrifuge retention capacity (CRC) of each aerogel was measured as follows. A dry aerogel sample was soaked in a model liquid (10 mL). The soaked aerogel was then paper- and air-dried for 5 minutes followed by centrifuging (EPPENDORF 5810) the sample in a filter-fitted centrifuge tube. The weight of the centrifuged aerogel sample was taken at 400, 700, 2000 and 3000 rpm at different times. The CRC was then calculated using Equation 5: x 100 (Eq. 5), where W C RC is the weight of the centrifuged aerogel, and w 0 is the weight of the dry aerogel. An average value of three CRC measurements was determined for each aerogel.
  • Equations 6 and 7 show the integrated form of the pseudo-first and second-order rate laws:
  • Qm or ⁇ Jm (g/g) is the maximum absorption capacity of an aerogels.
  • Q t or q t (g/g) is the absorption capacity at a particular time
  • t is the time the aerogel spent in the container containing the DI water or other fluid
  • i is the absorption rate constant for pseudo-first order and can be obtained as a slope of In ( Qm ) versus t plot (Eq. 6).
  • k 2 is the Qm ⁇ Qt absorption rate constant for pseudo-second order which is the inverse of the intercept x q n from the (t/qt) versus t plot (Eq. 7).
  • FIG. 1 represents a typical scheme used herein for synthesizing hybrid hydrogels and hybrid aerogels. In the first steps (represented by the three left-most flasks in FIG.
  • hybrid hydrogels were prepared comprising alpha-1 ,3- glucan and a metal hydroxide [Mg(OH) 2 , Ca(OH) 2 , or Ti(OH) 2 ], and hybrid aerogels were prepared comprising alpha-1 , 3-glucan and a metal oxide (MgO, CaO, or TiO 2 ).
  • metal hydroxide Mg(OH) 2 , Ca(OH) 2 , or Ti(OH) 2
  • hybrid aerogels were prepared comprising alpha-1 , 3-glucan and a metal oxide (MgO, CaO, or TiO 2 ).
  • the difference in the gelation kinetics of the hydrogels upon introduction of the inorganic salts was investigated by conducting oscillatory time sweep tests.
  • the storage modulus (G') and loss modulus (G") for hybrid alpha-1 , 3-glucan hydrogels (2 wt% inorganic, dry solids basis [dsb] [dsb is also referred to as dry weight basis, or dwb, herein]) and neat alpha-1 ,3-glucan hydrogel was evaluated.
  • the neat alpha-1 ,3- glucan hydrogel the onset of storage modulus increase was seen after ⁇ 40 minutes of gelation time.
  • the hybrid compositions exhibited G’ increase immediately, but the slope of this growth differed.
  • Mg(OH) 2 /glucan hydrogel followed by Ti(OH) 4 /glucan and Ca(OH) 2 /glucan hydrogels, exhibited larger G’ at the onset of gelation and proceeded with a larger rate of gelation, indicating more pronounced coupling between their constituent particles, resulting in fast formation of network.
  • the Brunauer-Emmett-Teller (BET) specific surface area for the neat glucan aerogel and selected hybrid (2 wt% inorganic) aerogels was evaluated.
  • the TiO 2 /glucan aerogel exhibited the highest BET specific surface area of 82.1058 m 2 /g, almost twice as high as the neat glucan aerogel.
  • Given the smaller ionic radius and tetravalent nature of Ti 4+ favor multidentate binding of TiO 2 to the glucan particle for the formation of smaller pore sizes and higher pore volume per aerogel mass (0.1371 cm 3 /g), such phenomenon could aid N 2 gas adsorption and desorption processes resulting in higher surface area.
  • the effect of small ionic radius of metal for engineering small pore sizes and high pore volume (0.0883 cm 3 /g) was also revealed in the MgO/glucan aerogel with which a higher surface area of 53.3294 m 2 /g was obtained as compared to CaO/glucan aerogel (37.1272 m 2 /g).
  • the CaO/glucan aerogel had larger pore sizes, and weak adsorption and retention of purged N 2 gas, resulting in smaller pore volume (0.0617 cm 3 /g).
  • the surface area for the neat glucan aerogel was 44.6942 m 2 /g, while its pore volume was 0.0748 cm 3 /g.
  • Hydrogel Density Characterization The density of the hydrogels showed some effect on the properties of the aerogels. When compared to a neat glucan hydrogel, the hybrid hydrogels produced above displayed reasonable stability in water when the inorganic salt loading used in hydrogel production was ⁇ 20 wt% (dsb); beyond that level, the hybrid hydrogels lost their mechanical strength and dispersed in water.
  • Mg(OH) 2 -glucan, Ca(OH) 2 -glucan, and Ti(OH) 4 -glucan hybrid hydrogels exhibited densities of about 964.2, 992.1 , and 997.2 kg rm 3 , respectively.
  • Hybrid aerogels retained nanocrystalline structures, and the metals (inorganics) took the crystal pattern of the glucan by showing hexagonal structure.
  • the inorganics in the hybrid aerogels were in oxide forms according to the XRD analysis suggesting that the freeze-drying transformed the metal hydroxides (of the hydrogels) into metal oxides through water removal.
  • the TiO 2 peaks matched well with the JCPDS of card No. 33-1381 .
  • the major peaks of the TiO 2 were found at 31 .5°, 33.5°, 37.2°, 39.0°, 55.1 °, 57.2°, and 61.3° with a crystalline plane of (0 02), (2 1 1), (3 0 1), (2 2 0), (4 1 1), (2 1 3), and (4 2 0), respectively.
  • the average crystallite size of the TiO 2 was calculated to be 34.4 nm. The smaller crystallite size aids the growth of TiO 2 nanocrystals in the glucan network.
  • CaO-glucan aerogel exhibited extra peaks at 24.1°, 26.7°, 29.7°, 35.5°, 39.4°, 43.2°, 47.5°, and 48.3° assigned to CaO crystalline plane with JCPDS No. 28-0775.
  • the average crystallite size of the CaO was found to be 43.1 nm.
  • the crystal structure of MgO-glucan aerogel had an extra peak corresponding to MgO and Mg(OH) 2 with JCPDS No. 30-0794 07-0239, respectively.
  • the presence of the Mg(OH) 2 in the aerogel can be attributed to the hygroscopic nature of MgO.
  • the major peak of the Mg(OH) 2 overlapped with MgO at 38.0° having a crystalline plane of (1 0 1) suggesting in situ conversion of the MgO to Mg(OH) 2 under ambient conditions after removing the aerogel product from the freeze-dryer.
  • Mg(OH) 2 has other crystalline planes of (0 0 1), (1 0 0), (1 0 2), (1 1 0), (1 1 1), (1 0 3), and (2 0 0), while MgO exhibits crystalline planes of (4 0 0), (5 1 1), and (4 4 0).
  • the average crystallite size of the Mg(OH) 2 and MgO in the MgO-glucan aerogel were found to be 31.5 and 29.2 nm, respectively.
  • the hybrid aerogels as prepared above had 0.5, 2, or 10 wt% of TiO 2 , CaO, or MgO/Mg(OH) 2 .
  • increase in the metal oxide component (and hydroxide component if Mg) changed the crystallinity and crystallite sizes of the glucan.
  • the metal component was >2 wt% of the hybrid aerogel, high crystallinity was recorded and the crystalline plane at 9.6° shifted to 10.4°, indicating a dehydrated form of the glucan.
  • controlling the concentration of the inorganic precursors (metal salts) enabled preparation of hybrid aerogels with controlled physicochemical properties.
  • the metal oxide/hydroxide component could be used to engineer the crystallite size and interlayer distance of alpha-1 ,3-glucan.
  • the surface structure and morphology of neat glucan aerogel and hybrid aerogels were revealed using SEM. SEM imaging showed that each aerogel exhibited a characteristic honeycomb microstructure with an open-porous surface in an interwoven network.
  • the honeycomb microstructure of the neat glucan aerogel displayed a tear morphology along the growth direction of the hexagonal-like honeycomb microstructure (FIG. 2a).
  • the open pores were ⁇ 10 to ⁇ 20 pm and appeared typically in between stacked layers of honeycomb structure with an average thickness of about 1.4 pm (FIG. 2a inset).
  • the pore walls contained nanosheet structures with an average thickness of -0.545 pm and randomly distributed nanopores of 50 to 250 nm diameter.
  • the hybrid aerogels exhibited changes in morphology in that unidirectional growth of microstructure with hexagonal prism shape was obtained (FIGs. 2a-d).
  • the hybrid aerogels also showed less or no tear morphology as compared to the neat glucan aerogel. This indicates that the mechanical strengths of the hybrid aerogels were superior, which aids the unidirectionally undistorted growth of the honeycomb microstructure with hexagonal prism shapes.
  • Other interesting features that were observed were an increase in the thickness of nanosheet layers of the honeycomb microstructure and smaller pore sizes of the nanosheet layer.
  • the open pores existing between the interlayers of MgO-glucan aerogel nanosheets had an average size of -8 pm (FIG. 2b), and the nanosheet layer had a thickness of 2.5 pm (inset of FIG. 2b).
  • the pores of the nanosheet layer had a pore size in the range of 10 to 150 nm as measured along the x-axis direction.
  • the CaO-glucan aerogel exhibited similar phenomenon in that the open pore at the interlayer was -8.5 pm (FIG. 2c), and the nanosheet thickness was 1.5 pm (inset of FIG. 2c); the pores at the nanosheet layer were in the range of 10 to 170 nm, which was slightly larger than the nanosheet layer pores of the MgO-glucan aerogel. This indicates that metal ionic radius might also play a role in the pore size arrangement similar to what was observed in the hydrogels. The greater reduction in open pore size and increase in the nanosheet layer could be attributed to the growth of the metal oxide along the basal plane of the glucan, which could be responsible for the higher mechanical strength observed in the hybrid hydrogels.
  • the TiO2- glucan aerogel showed the smallest open pores and thickest nanosheet layer, which were found to be 7.8 pm (FIG. 2d) and 2.7 pm (inset of FIG. 2d), respectively; the pore size at the nanosheet layer was also found to be the smallest in the range of 5 to 140 nm.
  • the transition metal oxide, TiO2 could exhibit multivalent hydrogen bonding with the glucan due to tetravalent nature of the Ti metal. This could also explain the superior mechanical strength observed in the Ti(OH) 4 -glucan hydrogel.
  • EDS analysis was used for estimating the chemical compositions of the neat glucan and hybrid glucan aerogels.
  • the major peaks appearing in the EDS spectra could be assigned to the elements in the aerogels.
  • a good distribution of Ti was observed in the TiO2-glucan aerogel, as compared to the distribution of Mg and Ca in the MgO-glucan and CaO-glucan aerogels, respectively. This can be attributed the tetravalent nature of the Ti which allow multivalent hydrogen bonding with glucan.
  • Identification of Functional Groups of Aerogels The structures of both neat glucan and hybrid aerogels were further examined using FTIR spectroscopy to identify different functional groups in the materials.
  • Neat glucan and hybrid aerogels exhibited similar FTIR spectra, except for the additional vibrational bands at the lower wave number of ⁇ 500 cm- 2 in the hybrid aerogels.
  • the extra peaks are characteristic vibrational bands of metal-oxygen-metal (M-O-M) signals. This shows that the molecular structure of the glucan is somehow retained after inclusion of the metal oxide.
  • these peaks were almost absent in the case of neat glucan aerogel. This proves that both the neat glucan and hybrid aerogels were successfully synthesized via the co-precipitation method, while only the precursors for the intercalated metal oxides were changed.
  • the O-H stretching bands of the hybrid aerogels should have different behavior as compared to neat glucan aerogel. This would further aid the understanding of the chemical interaction between glucan and metal oxide.
  • the spectra of each aerogel in the region of 4000 to 3100 cm’ 1 was expanded and carefully analyzed.
  • the O-H stretching bands of the hybrid aerogels showed broader shape with reduced intensity of transmittance as compared to that of the neat glucan aerogel.
  • the O-H stretching mode of TiO2-glucan aerogel had the lowest intensity indicating superior chemical interaction and networking between TiO2 and glucan. Moreover, the O-H stretching band of the CaO- glucan aerogel underwent a slight shift to a lower frequency region suggesting that Ca-0 species might induce a wider interlayer distance between the crystal plane of the glucan similar to what was observed in the hydrogel analysis.
  • the thermal stability of the neat glucan and hybrid glucan aerogels was examined using TGA, which was performed from 20 to 600 °C.
  • a heat resistance curve versus temperature of the aerogels was prepared, showing that the neat glucan aerogel exhibited an initial weight loss at a lower temperature as compared to the hybrid glucan aerogels (each of 2 wt% metal oxide).
  • the neat glucan aerogel exhibited a sharp weight loss (91 %) beginning at 200 °C and ending at 420 °C, which could be due to thermal degradation of the glucan.
  • all of the hybrid aerogels containing 2 wt% metal oxide displayed superior heat-resistance curves where a sharp weight loss (-90%) was observed beginning at 250 °C and ending at 420 °C for all the samples.
  • the remaining weight that was the inorganic phase was retained up to 475-600 °C, depending on which metal oxide was present.
  • different weight loss and lower heat-resistance was experienced. Sharp weight loss began at -170 °C and ended between 350-380 °C depending on the metal oxide present.
  • the deconvoluted peaks of oxygen in all of the aerogels were observed.
  • TiO2-glucan aerogel showed an additional peak at 530.20 eV corresponding to Ti-0 interaction in the structure.
  • the addition peaks could be found at 529.90 and 530.24 eV for Ca-0 and Mg- O/Mg-(OH) 2 interaction, respectively.
  • the sub-components of the C 1s in the aerogels were observed.
  • the C 1s peak of the neat glucan aerogel could be deconvoluted into three sub-peaks while that of the hybrid glucan aerogels could be deconvoluted into four sub-peaks.
  • C-C signals showed lower area coverage and intensity.
  • the TiO2-glucan aerogel showed a C-C signal with smallest area coverage and intensity.
  • the XPS peaks of the metals in the hybrid aerogels showed poor resolution due to their amount and interlayer entrapment within the glucan structure. However, these peaks were carefully analyzed and deconvoluted into different sub-components.
  • the Ti 2p peak could be deconvoluted into four sub-components where peaks at 455.77 and 461.57 eV were assigned to the Ti 2p 3 /2 and Ti 2pi/ 2 species of TO2 present in the TiO 3 - glucan aerogels.
  • the XPS analysis revealed that a trace Ti 2 O 3 phase might be present in the sample with Ti 2p 2 / 3 and Ti 2pi/ 2 having a binding energy at 457.69 and 464.17 eV, respectively.
  • the Ca 2p peak of the CaO present in the CaO-glucan aerogel was deconvoluted into two peaks where the Ca 2p 3/2 and Ca 2pi/ 2 species were found at 345.15 and 348.70 eV, respectively.
  • the Mg 2p peak of the MgO-glucan aerogel was deconvoluted into two peaks at 47.74 and 49.98 eV which could be assigned, respectively, to the MgO and Mg(OH) 2 phases of the aerogel. All of these data indicate that the metal oxides were successfully dispersed in the structure of the glucan, thereby giving rise to functionalized glucan aerogels.
  • Aerogels The mechanical properties such as yield stress and compressive modulus of the neat glucan and hybrid glucan aerogels were evaluated to determine their shock and wear resistance capacities. Aerogels in cylindrical form were used for in-plane compressive testing to obtain force (N) versus time (s) plots. Three distinct regions were observed from each plot: a linear (elastic) region, a plasticity region, and a densification region. The end of the elastic region is considered as yield stress (i.e. , stress point at which the aerogels undergo permanent deformation).
  • the hybrid aerogels When compared to the neat glucan aerogel, the hybrid aerogels showed wider elastic regions with superior performance displayed by the TiO2-glucan aerogel followed by the CaO-glucan and MgO-glucan aerogels. This indicated that the hybrid aerogels exhibited stronger resistance to cell wall bending at low strain.
  • MgO-glucan aerogel exhibited a yield stress and compressive modulus of -0.03055 kPa and 0.06706 kPa, respectively, while those for the CaO-glucan aerogel were found to be 0.03015 kPa and 0.06827 kPa, respectively.
  • the TiC>2-glucan aerogel exhibited the highest ductile-like behaviors with up to 60% strain function at yield stress and compressive modulus of 0.04574 kPa and 0.08951 kPa, respectively. This indicated that the TiO2-glucan aerogel microstructure possessed the strongest networking.
  • the hybrid glucan aerogels were further shown to have superior mechanical properties over the neat glucan aerogel.
  • the neat glucan aerogel was completely broken into pieces at a strain function of -20% due to having a weak microstructure.
  • MgO-glucan and TiO2-glucan aerogels showed no cracks throughout the compression test.
  • the only densification of the hybrid aerogels was observed at a higher strain function of >30% followed by deformation without any noticeable cracks.
  • CaO-glucan aerogel displayed a noticeable crack around the cell wall at the strain function of >30%. This was due to larger nanopore sizes in the CaO-glucan aerogel as discussed above.
  • the mechanical strength of glucan aerogels was investigated after being subjected to water uptake for 100 s. This study was conducted by adding 10 mL of deionized water into a cylindrical tube containing a glucan aerogel with a known weight. After 100 s (this time is expected to be water uptake time to reach saturation), the aerogels were removed and dried at room temperature for 5 minutes followed by compressive testing. Compressive loading curves were prepared with each saturated aerogel. Similar to what was observed in dried form, the hybrid glucan aerogels exhibited slight increases in mechanical strength as compared to the glucan aerogel. This suggests that a moisture environment would have little or no effect on the hybrid aerogel compositions.
  • Each hybrid glucan aerogel exhibited improved water absorption capacity with increasing time as compared to neat glucan aerogel in an in-plane absorption assay (FIG. 3). Somewhat similar absorption capacities were observed for all the aerogels at ⁇ 30 seconds. However, the TiO2-glucan aerogel displayed a noticeably improved absorption capacity within the absorption time period of 40 to 100 seconds, while MgO- glucan and CaO-glucan aerogels only showed a marginal improvement as compared to the neat glucan aerogel by the 100 second time period.
  • the TiO 2 -glucan aerogel exhibited a maximum water absorption capacity of -20.0 g/g, while the MgO-glucan and CaO-glucan aerogels had a maximum water absorption capacity of about 17.9 g/g and the neat glucan aerogel had an absorption capacity of about 17.0 g/g.
  • hybrid glucan aerogels, particularly TiO 2 -glucan aerogel, with 2 wt% metal oxide could aid faster diffusion of water into an aerogel matrix.
  • the water absorption capacity of the aerogels under load was also investigated (FIG. 3 inset). Water absorption under load was conducted by placing a steel weight (-100 g) directly on the aerogel (-100 mg) in a cylindrical container. Each aerogel under load was allowed to stand for 100 seconds in the container with water. There was a modest drop in the absorption capacities of the glucan aerogels under load as compared to the aerogels without load.
  • the TiO 2 - glucan aerogel possessed the highest water uptake capacity (13.19 g/g), while the neat glucan, MgO-glucan and CaO-glucan aerogels were found to have water uptake capacities of 9.55, 11.19 and 12.82 g/g, respectively.
  • the water absorption capacities of a commercial diaper and commercial sanitary pad under load were also measured, and found to be 43.18 and 13.90 g/g, respectively.
  • the water absorption capacity of aerogels was also tested with an aqueous NaCI solution (0.01 g/ml_, “saline”, model for urine) (FIG. 4) or various aqueous glycerol solutions (1 :10, 1 :1 , 5:1 glycerol :water [models for menstrual fluid]) (v/v) (FIGs. 5A-C). Tests were conducted as above, with or without load. The absorption capacities of a commercial diaper and sanitary pad under load in saline were measured to be about 17.50 and 4.6 g/g, respectively. The absorption capacities of a commercial diaper and sanitary pad under load in aqueous glycerol solution were also measured (FIG. 5C).
  • Aerogel Formation Mechanism A mechanism for aerogel formation was proposed based on the in-depth understanding gained from the FTIR, XRD, SEM, TGA, rheology and confocal results of the present study.
  • oxygen atoms available for intramolecular interaction (i.e. , the oxygen at the hydroxyl groups [O-H interaction], and at the ring [C-O- interaction]). They can be found at C2, C4, C6 (O-H group) and C1 , C3 and C5 (C-0 group), respectively.
  • the charge on the oxygen at the hydroxyl (C2, C4, C6) is more negative than that on the C1 , C3 and C5 because of the hydrogen ion (H + effect).
  • H + effect hydrogen ion
  • the oxygen at 02, 04, and 06 interacts more readily with cations such as Na + , Ca + , Mg + , and Ti + by displacing H + .
  • Na + is in excess, and hence effectively interacts with those oxygens causing structural weakening, and particle dissolution.
  • the gelation process was enhanced after introducing foreign particles (hybrid materials) due to intermolecular hydrogen bonding.
  • the presence of Mg + , Ca + , or Ti((OH)3OCH(CH 3 )2)4 in the alpha-1 , 3-glucan solution (with excess NaOH) resulted in an ionic exchange process.
  • Na + reacted with Ch present when magnesium chloride or calcium chloride was used
  • (OH) 3 OCH(CH 3 )2 anion and Mg 2+ , Ca 2+ or Ti 4+ replaced Na + attached to the oxygen at C2, C4, C6.
  • pH was reduced reinforced structures were obtained because of the elimination of some of the NaOH species.
  • Ca 2+ , Mg 2+ and Ti 4+ were likely to undergo different coordination with the alpha-1 , 3-glucan structure.
  • Ca 2+ and Mg 2+ , and Ti 4+ formed two-points, and four-points, coordination with glucan structure, respectively, and hence produced MgO and CaO, and TiC>2, at the alpha-1 , 3-glucan structure.
  • O-H stretch, C-0 and C-O-C interaction (intramolecular interaction) of the alpha-1 , 3-glucan structure was found reduced (FTIR and XPS results) in the hybrid samples due to the intermolecular hydrogen.
  • TiC>2 produced multivalent hydrogen bonding, which improved surface area, pore volume, and structural integrity.
  • a detailed characterization of the aerogels revealed that the functional groups (O-H, C-O, C-O-C, C-O-H, and C-C) of alpha-1 ,3- glucan were successfully modulated upon in situ introduction of MgO, CaO, or TiO2 due to intermolecular hydrogen bonding formation.
  • three different model fluids DI water as baseline, saline water as urine, glycerol/water solution as menstrual discharge
  • DI water DI water as baseline, saline water as urine, glycerol/water solution as menstrual discharge
  • the hybrid glucan aerogels showed improved fluid uptake performance as compared to neat alpha-1 , 3-glucan aerogel.
  • TiO2/glucan aerogel displayed the greatest fluid absorption capacity in all of the above absorption demonstrations. This performance was attributed to superior structural network and integrity, surface area, pore volume, and smaller pore sizes resulting from effective intermolecular hydrogen bonding between TiO2 and alpha-1 , 3-glucan. It was also noteworthy that the absorption performance of hybrid glucan aerogels was generally superior to the absorption performance of commercial superabsorbents against liquid models of urine and menstrual fluid.
  • Formulations were developed and used to prepare molded microcellular foams comprising at least polyurethane and alpha-1 , 3-glucan. Such molded foams can be used in applications such as footwear (e.g., insoles) or other applications that employ cushioning materials, for example.
  • the foams were prepared using the materials listed in Table 1 and following the criteria listed in Tables 2-3.
  • Additional molded foams were prepared to examine the effects of including (i) SUSTERRA (propanediol) only, or (ii) a combination of SUSTERRA and NUVOLVE (alpha-1 , 3-glucan), as bio-derived components of the prepared foam.
  • the foam product INSITE ECOCOMFORT TERRAIN F71 comprised about 50 wt% SUSTERRA
  • the foam product INSITE ECOCOMFORT TERRAIN IF99 comprised about 45 wt% SUSTERRA and about 5 wt% NUVOLVE.
  • Both the F71 and IF99 products comprised about 50 wt% petrol-based diisocyanate polyurethane. Properties of these molded foams are listed in T able 6.

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Analytical Chemistry (AREA)
  • Dispersion Chemistry (AREA)
  • Cosmetics (AREA)
  • Colloid Chemistry (AREA)
  • Compositions Of Macromolecular Compounds (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)

Abstract

Des compositions sont divulguées comprenant un aérogel ou un hydrogel. L'aérogel ou l'hydrogel comprend un alpha-glucane insoluble dans l'eau et un oxyde métallique. Au moins environ 50 % des liaisons glycosidiques de l'alpha-glucane insoluble dans l'eau sont des liaisons alpha-1,3, et l'oxyde métallique est choisi parmi l'oxyde de calcium, l'oxyde de magnésium, le dioxyde de titane ou tout autre oxyde métallique approprié. Sont également divulgués des procédés de production d'aérogels et d'hydrogels, ainsi que des procédés d'utilisation de ces matériaux, tels que dans des techniques d'absorption. Sont également divulgués d'autres types de matériaux contenant un alpha-glucane insoluble dans l'eau.
PCT/US2024/035735 2023-06-30 2024-06-27 Compositions poreuses d'alpha-1,3-glucane WO2025006691A2 (fr)

Applications Claiming Priority (6)

Application Number Priority Date Filing Date Title
US202363511292P 2023-06-30 2023-06-30
US202363511286P 2023-06-30 2023-06-30
US63/511,286 2023-06-30
US63/511,292 2023-06-30
US202463573627P 2024-04-03 2024-04-03
US63/573,627 2024-04-03

Publications (2)

Publication Number Publication Date
WO2025006691A2 true WO2025006691A2 (fr) 2025-01-02
WO2025006691A3 WO2025006691A3 (fr) 2025-02-27

Family

ID=91966355

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2024/035735 WO2025006691A2 (fr) 2023-06-30 2024-06-27 Compositions poreuses d'alpha-1,3-glucane

Country Status (1)

Country Link
WO (1) WO2025006691A2 (fr)

Citations (110)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2627858A (en) 1950-11-03 1953-02-10 Margaret E Miller Disposable diaper
US3187747A (en) 1962-03-05 1965-06-08 Johnson & Johnson Surgical absorbent pad having ion exchange properties
US3322123A (en) 1964-06-17 1967-05-30 Tampax Inc Tampons
US3585998A (en) 1968-03-29 1971-06-22 Ncr Co Disposable diaper with rupturable capsules
US3749094A (en) 1971-08-18 1973-07-31 Procter & Gamble Tampon with string attached to its proximal end
US3964486A (en) 1974-08-19 1976-06-22 The Procter & Gamble Company Disposable diaper containing ammonia inhibitor
US4079739A (en) 1976-12-27 1978-03-21 Kimberly-Clark Corporation Die-cut contoured catamenial napkin of multi-layered construction
US4397644A (en) 1982-02-04 1983-08-09 Kimberly-Clark Corporation Sanitary napkin with improved comfort
US4462917A (en) 1982-09-27 1984-07-31 Halliburton Company Method and compositions for fracturing subterranean formations
US4464270A (en) 1982-09-27 1984-08-07 Halliburton Company Method and compositions for fracturing subterranean formations
US4477360A (en) 1983-06-13 1984-10-16 Halliburton Company Method and compositions for fracturing subterranean formations
US4623339A (en) 1985-08-15 1986-11-18 Joann Ciraldo Precious baby diaper
US4762521A (en) 1986-04-11 1988-08-09 Kimberly-Clark Corporation Absorbent garment with quilted and conformable absorbent pad
US4781713A (en) 1987-06-10 1988-11-01 Sherwood Medical Company Incontinence pad for females
US4799550A (en) 1988-04-18 1989-01-24 Halliburton Company Subterranean formation treating with delayed crosslinking gel fluids
US4840734A (en) 1987-11-25 1989-06-20 Johnson Edward R Process for absorbing liquid leaks and spills
US4846824A (en) 1984-05-21 1989-07-11 Kimberly-Clark Corporation Labial sanitary pad
US4865855A (en) 1988-01-11 1989-09-12 Kimberly-Clark Corporation Antimicrobial absorbent food pad
US4894179A (en) 1987-10-13 1990-01-16 Exxon Research And Engineering Company Absorbent composition containing a tertiary amino azabicyclic alcohol and an amine salt
US4925453A (en) 1988-08-10 1990-05-15 Sealed Air Corporation Absorbent blood wipe pad and method
US5176930A (en) 1991-04-15 1993-01-05 Sealed Air Corporation Food package and absorbent pad with edge wicking
US5342543A (en) 1991-05-28 1994-08-30 Data Medical Associates, Inc. Neutralizing absorbent for acids and bases
US5342343A (en) 1991-08-28 1994-08-30 Uni-Charm Corporation Disposable training pants
US5456733A (en) 1993-09-08 1995-10-10 The Penn State Research Foundation Pelletized mulch composition and process for preparing same
US5462539A (en) 1994-06-30 1995-10-31 Herman; Ella H. Hygiene (incontinence) pad for catheter users
US5683813A (en) 1994-08-31 1997-11-04 The United States Of America As Represented By The Administrator Of The National Aeronautics And Space Administration Absorbent pads for containment, neutralization, and clean-up of environmental spills containing chemically-reactive agents
US5701617A (en) 1997-03-21 1997-12-30 Colby; Gerard Joseph Absorbent bedsheet
US5820619A (en) 1997-08-01 1998-10-13 Chen; Chuan Mei Sanitary napkin with hump and groove
WO1998046159A1 (fr) 1997-04-15 1998-10-22 Minnesota Mining And Manufacturing Company Carre absorbant s'utilisant avec des champs operatoires
US5849210A (en) 1995-09-11 1998-12-15 Pascente; Joseph E. Method of preventing combustion by applying an aqueous superabsorbent polymer composition
US5906952A (en) 1997-03-07 1999-05-25 Nordlys S.A. Single layer absorbent cable wrap
WO1999037261A1 (fr) 1998-01-23 1999-07-29 The Procter & Gamble Company Garniture absorbante pour incontinents avec systeme de fixation ameliore
US6091492A (en) 1994-04-15 2000-07-18 Micromeritics Instrument Corporation Apparatus and method for determining the size distribution of particles by light scattering
US6183456B1 (en) 1997-06-16 2001-02-06 The Procter & Gamble Company Feminine hygiene system and kit using an absorbent interlabial device
US6191341B1 (en) 1998-04-21 2001-02-20 Ronald D. Shippert Medical absorbent pack substantially free of unwanted adhesion properties
US20010014797A1 (en) 2000-01-12 2001-08-16 Migaku Suzuki Absorbent incontinence pads
US20020087138A1 (en) 2000-12-08 2002-07-04 Eje Osterdahl Absorbent articles with improved leakage safety
US20020147483A1 (en) 1997-10-08 2002-10-10 Bumbarger Scott A. Protective multi-layered liquid retaining composite
US20030070232A1 (en) 2001-10-12 2003-04-17 Darlene Diak/Ghanem Quick change bedsheet set
US6579273B2 (en) 2000-07-18 2003-06-17 Tereson R. Dupuy Reusable baby diaper having reusable absorbent insert
US6695138B1 (en) 2001-07-16 2004-02-24 Commodaic Machine Co. Inc. Food package with integral juice absorbing bottom
US20040074271A1 (en) 2002-10-15 2004-04-22 Krysiak Michael Dennis Soil stabilizer carrier
US6741350B2 (en) 2000-05-16 2004-05-25 Horiba, Ltd. Particle size distribution measuring apparatus with validation and instruction modes
US20040128764A1 (en) 2003-01-06 2004-07-08 Mcgrath Deborah Easily changeable absorbent panel for bed clothing
US20040167491A1 (en) 2001-05-22 2004-08-26 Uni-Charm Corporation Interlabial product having form for finger securement, and individual package
US20050008737A1 (en) 2003-07-07 2005-01-13 Young-Won Kwon Absorbent pad for absorbing liquid exuding from food
US20050256486A1 (en) 2004-05-14 2005-11-17 Carasso Samuel C Fluid management device with fluid transport element for use within a body
US7000000B1 (en) 1999-01-25 2006-02-14 E. I. Du Pont De Nemours And Company Polysaccharide fibers
US20060172048A1 (en) 2005-01-21 2006-08-03 Etchells Marc D Food preservation systems
US20070287971A1 (en) 2006-03-31 2007-12-13 The Procter & Gamble Company Absorbent articles with feedback signal upon urination
US20080112907A1 (en) 2006-11-03 2008-05-15 Chan Anita N Dispersible cationic polygalactomannan polymers for use in personal care and household care applications
US20080199577A1 (en) 2007-02-21 2008-08-21 Paper-Pak Industries Consumer food storage package with absorbent food pad
US7459501B2 (en) 2004-08-27 2008-12-02 Absorbent Technologies, Inc. Superabsorbent polymers in agricultural applications
US7567739B2 (en) 2007-01-31 2009-07-28 Draka Comteq B.V. Fiber optic cable having a water-swellable element
US20090204091A1 (en) 2001-05-22 2009-08-13 Uni-Charm Corporation Interlabial pad
US7670513B2 (en) 2003-07-23 2010-03-02 Basf Aktiengesellschaft Fire control composition and method
US7732657B2 (en) 2002-12-20 2010-06-08 The Procter & Gamble Company Absorbent article with lotion-containing topsheet
US20100241098A1 (en) 2006-08-02 2010-09-23 James Roy Brownlee Diapering system using re-usable diaper shell with replaceable absorbent insert and method of manufacture of same
US20110137277A1 (en) 2008-07-07 2011-06-09 Dry Like Me Limited Absorbent pad
US20120328723A1 (en) 2006-01-25 2012-12-27 Absorbent Technologies, Inc. Methods for producing superabsorbent polymers for use in agricultural applications
US20130018112A1 (en) 2009-09-14 2013-01-17 University Of Nottingham Cellulose nanoparticle aerogels, hydrogels and organogels
US20130244288A1 (en) 2011-09-09 2013-09-19 E I Du Pont De Nemours And Company High titer production of poly (alpha 1,3 glucan)
US20130281949A1 (en) 2007-10-12 2013-10-24 Lori Lee Periman Potty training liners
US8859758B2 (en) 2004-06-21 2014-10-14 Evonik Degussa Gmbh Water-absorbing polymer
US8871474B2 (en) 2012-09-25 2014-10-28 E. I. Du Pont De Nemours And Company Glucosyltransferase enzymes for production of glucan polymers
US8912383B2 (en) 2005-04-29 2014-12-16 Kimberly-Clark Worldwide, Inc. Dual mode absorbent tampon
US20150064748A1 (en) 2013-09-05 2015-03-05 E I Du Pont De Nemours And Company Process for producing aplha-1,3-glucan polymer with reduced molecular weight
US8987543B1 (en) 2013-10-30 2015-03-24 Lillian A. Watson Sizeable sanitary or incontinence pad with med alerts
US20150191550A1 (en) 2014-01-06 2015-07-09 E I Du Pont De Nemours And Company Production of poly alpha-1,3-glucan films
US9089730B2 (en) 2010-11-25 2015-07-28 Zzakey Technologies Ltd Biodegradable fire-fighting formulation
US20150232785A1 (en) 2014-02-14 2015-08-20 E I Du Pont De Nemours And Company Polysaccharides for viscosity modification
US20150232819A1 (en) 2014-02-14 2015-08-20 E I Du Pont De Nemours And Company Glucosyltransferase enzymes for production of glucan polymers
US9161860B2 (en) 2009-08-24 2015-10-20 Paper-Pak Industries Removable absorbent pad for transporter
US20150368594A1 (en) 2014-06-19 2015-12-24 E I Du Pont De Nemours And Company Compositions containing one or more poly alpha-1,3-glucan ether compounds
US20150368595A1 (en) 2014-06-19 2015-12-24 E I Du Pont De Nemours And Company Compositions containing one or more poly alpha-1,3-glucan ether compounds
WO2015200590A1 (fr) 2014-06-26 2015-12-30 E.I. Du Pont De Nemours And Company Compositions de solution de poly(alpha -1,3-glucane)
WO2015200612A1 (fr) 2014-06-26 2015-12-30 E. I. Du Pont De Nemours And Company Production de boyaux à usage alimentaire à base de poly(alpha-1,3-glucane)
US20160058045A1 (en) 2014-08-26 2016-03-03 Pepsico, Inc. Method of Loading Flavor into an Aerogel and Flavor Impregnated Aerogel Based on Food Grade Materials
US20160068650A1 (en) 2013-05-03 2016-03-10 National University Of Singapore Polysaccharide aerogel
US9297737B2 (en) 2004-03-06 2016-03-29 Michael Trainer Methods and apparatus for determining characteristics of particles
US20160122445A1 (en) 2014-11-05 2016-05-05 E I Du Pont De Nemours And Company Enzymatically polymerized gelling dextrans
US20160177471A1 (en) 2013-06-18 2016-06-23 Lenzing Ag Polysaccharide fibers and method for producing same
US20160175811A1 (en) 2014-12-22 2016-06-23 E I Du Pont De Nemours And Company Polysaccharide compositions for absorbing aqueous liquid
WO2016133734A1 (fr) 2015-02-18 2016-08-25 E. I. Du Pont De Nemours And Company Éthers polysaccharidiques de soja
US20160304629A1 (en) 2013-12-16 2016-10-20 E. I. Du Pont De Nemours And Company Use of poly alpha-1,3-glucan ethers as viscosity modifiers
US20160311935A1 (en) 2013-12-18 2016-10-27 E. I. Du Pont De Nemours And Company Cationic poly alpha-1,3-glucan ethers
US20160333157A1 (en) 2014-01-17 2016-11-17 E. I. Du Pont De Nemours And Company Production of a solution of cross-linked poly alpha-1,3-glucan and poly alpha-1,3-glucan film made therefrom
US20170002336A1 (en) 2015-06-17 2017-01-05 E I Du Pont De Nemours And Company Modified glucosyltransferases for producing branched alpha-glucan polymers
US20170283568A1 (en) 2013-04-10 2017-10-05 Lenzing Ag Polysaccharide film and method for the production thereof
US20180021238A1 (en) 2015-02-06 2018-01-25 E I Du Pont De Nemours And Company Colloidal dispersions of poly alpha-1,3-glucan based polymers
US20180022834A1 (en) 2015-04-03 2018-01-25 E I Du Pont De Nemours And Company Oxidized dextran
US20180079832A1 (en) 2015-04-03 2018-03-22 E I Du Pont De Nemours And Company Oxidized soy polysaccharide
US20180230241A1 (en) 2015-08-28 2018-08-16 E I Du Pont De Nemours And Company Benzyl alpha-(1->3)-glucan and fibers thereof
US20180237816A1 (en) 2015-04-03 2018-08-23 E I Du Pont De Nemours And Company Gelling dextran ethers
US20180273731A1 (en) 2015-02-06 2018-09-27 Lenzing Ag Polysaccharide suspension, method for its preparation, and use thereof
US20180340199A1 (en) 2017-05-23 2018-11-29 E I Du Pont De Nemours And Company Enzymatic production of alpha-1,3-glucan
US20190078062A1 (en) 2017-09-13 2019-03-14 E I Du Pont De Nemours And Company Engineered glucosyltransferases
US20190078063A1 (en) 2017-09-13 2019-03-14 E I Du Pont De Nemours And Company Engineered glucosyltransferases
US20190112456A1 (en) 2017-10-13 2019-04-18 E I Du Pont De Nemours And Company Flowable bulk granular polysaccharide
US10301604B2 (en) 2016-09-14 2019-05-28 E I Du Pont De Nemours And Company Engineered glucosyltransferases
US20190185893A1 (en) 2017-12-14 2019-06-20 E I Du Pont De Nemours And Company Alpha-1,3-glucan graft copolymers
US20190202942A1 (en) 2016-06-13 2019-07-04 E I Du Pont De Nemours And Company Detergent compositions
US20190225737A1 (en) 2016-07-22 2019-07-25 E I Du Pont De Nemours And Company Polyurethane polymers comprising polysaccharides
WO2019167013A1 (fr) 2018-03-02 2019-09-06 Materias S.R.L. Procédé de préparation d'un aérogel superabsorbant
US20190276806A1 (en) 2018-03-09 2019-09-12 E I Du Pont De Nemours And Company Engineered glucosyltransferases
US20190309096A1 (en) 2016-06-13 2019-10-10 E I Du Pont De Nemours And Company Detergent compositions
US20200131281A1 (en) 2018-10-25 2020-04-30 Dupont Industrial Biosciences Usa, Llc Alpha-1,3-glucan graft copolymers
US20200165360A1 (en) 2015-11-05 2020-05-28 E I Du Pont De Nemours And Company Dextran-poly alpha-1,3-glucan graft copolymers and synthesis methods thereof
WO2022235655A1 (fr) 2021-05-04 2022-11-10 Nutrition & Biosciences USA 4, Inc. Compositions comprenant un alpha-glucane insoluble
WO2023183280A1 (fr) 2022-03-21 2023-09-28 Nutrition & Biosciences USA 4, Inc. Compositions comprenant un alpha-glucane insoluble

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0975405B1 (fr) * 1997-04-18 2006-03-29 Cabot Corporation Utilisation d'aerogels comme agent d'adsorption

Patent Citations (115)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2627858A (en) 1950-11-03 1953-02-10 Margaret E Miller Disposable diaper
US3187747A (en) 1962-03-05 1965-06-08 Johnson & Johnson Surgical absorbent pad having ion exchange properties
US3322123A (en) 1964-06-17 1967-05-30 Tampax Inc Tampons
US3585998A (en) 1968-03-29 1971-06-22 Ncr Co Disposable diaper with rupturable capsules
US3749094A (en) 1971-08-18 1973-07-31 Procter & Gamble Tampon with string attached to its proximal end
US3964486A (en) 1974-08-19 1976-06-22 The Procter & Gamble Company Disposable diaper containing ammonia inhibitor
US4079739A (en) 1976-12-27 1978-03-21 Kimberly-Clark Corporation Die-cut contoured catamenial napkin of multi-layered construction
US4397644A (en) 1982-02-04 1983-08-09 Kimberly-Clark Corporation Sanitary napkin with improved comfort
US4462917A (en) 1982-09-27 1984-07-31 Halliburton Company Method and compositions for fracturing subterranean formations
US4464270A (en) 1982-09-27 1984-08-07 Halliburton Company Method and compositions for fracturing subterranean formations
US4477360A (en) 1983-06-13 1984-10-16 Halliburton Company Method and compositions for fracturing subterranean formations
US4846824A (en) 1984-05-21 1989-07-11 Kimberly-Clark Corporation Labial sanitary pad
US4623339A (en) 1985-08-15 1986-11-18 Joann Ciraldo Precious baby diaper
US4762521A (en) 1986-04-11 1988-08-09 Kimberly-Clark Corporation Absorbent garment with quilted and conformable absorbent pad
US4781713A (en) 1987-06-10 1988-11-01 Sherwood Medical Company Incontinence pad for females
US4894179A (en) 1987-10-13 1990-01-16 Exxon Research And Engineering Company Absorbent composition containing a tertiary amino azabicyclic alcohol and an amine salt
US4840734A (en) 1987-11-25 1989-06-20 Johnson Edward R Process for absorbing liquid leaks and spills
US4865855A (en) 1988-01-11 1989-09-12 Kimberly-Clark Corporation Antimicrobial absorbent food pad
US4799550A (en) 1988-04-18 1989-01-24 Halliburton Company Subterranean formation treating with delayed crosslinking gel fluids
US4925453A (en) 1988-08-10 1990-05-15 Sealed Air Corporation Absorbent blood wipe pad and method
US5176930A (en) 1991-04-15 1993-01-05 Sealed Air Corporation Food package and absorbent pad with edge wicking
US5342543A (en) 1991-05-28 1994-08-30 Data Medical Associates, Inc. Neutralizing absorbent for acids and bases
US5342343A (en) 1991-08-28 1994-08-30 Uni-Charm Corporation Disposable training pants
US5456733A (en) 1993-09-08 1995-10-10 The Penn State Research Foundation Pelletized mulch composition and process for preparing same
US6091492A (en) 1994-04-15 2000-07-18 Micromeritics Instrument Corporation Apparatus and method for determining the size distribution of particles by light scattering
US5462539A (en) 1994-06-30 1995-10-31 Herman; Ella H. Hygiene (incontinence) pad for catheter users
US5683813A (en) 1994-08-31 1997-11-04 The United States Of America As Represented By The Administrator Of The National Aeronautics And Space Administration Absorbent pads for containment, neutralization, and clean-up of environmental spills containing chemically-reactive agents
US5849210A (en) 1995-09-11 1998-12-15 Pascente; Joseph E. Method of preventing combustion by applying an aqueous superabsorbent polymer composition
US5906952A (en) 1997-03-07 1999-05-25 Nordlys S.A. Single layer absorbent cable wrap
US5701617A (en) 1997-03-21 1997-12-30 Colby; Gerard Joseph Absorbent bedsheet
WO1998046159A1 (fr) 1997-04-15 1998-10-22 Minnesota Mining And Manufacturing Company Carre absorbant s'utilisant avec des champs operatoires
US6183456B1 (en) 1997-06-16 2001-02-06 The Procter & Gamble Company Feminine hygiene system and kit using an absorbent interlabial device
US5820619A (en) 1997-08-01 1998-10-13 Chen; Chuan Mei Sanitary napkin with hump and groove
US20020147483A1 (en) 1997-10-08 2002-10-10 Bumbarger Scott A. Protective multi-layered liquid retaining composite
WO1999037261A1 (fr) 1998-01-23 1999-07-29 The Procter & Gamble Company Garniture absorbante pour incontinents avec systeme de fixation ameliore
US6191341B1 (en) 1998-04-21 2001-02-20 Ronald D. Shippert Medical absorbent pack substantially free of unwanted adhesion properties
US7000000B1 (en) 1999-01-25 2006-02-14 E. I. Du Pont De Nemours And Company Polysaccharide fibers
US20010014797A1 (en) 2000-01-12 2001-08-16 Migaku Suzuki Absorbent incontinence pads
US6741350B2 (en) 2000-05-16 2004-05-25 Horiba, Ltd. Particle size distribution measuring apparatus with validation and instruction modes
US6579273B2 (en) 2000-07-18 2003-06-17 Tereson R. Dupuy Reusable baby diaper having reusable absorbent insert
US20020087138A1 (en) 2000-12-08 2002-07-04 Eje Osterdahl Absorbent articles with improved leakage safety
US20040167491A1 (en) 2001-05-22 2004-08-26 Uni-Charm Corporation Interlabial product having form for finger securement, and individual package
US20090204091A1 (en) 2001-05-22 2009-08-13 Uni-Charm Corporation Interlabial pad
US6695138B1 (en) 2001-07-16 2004-02-24 Commodaic Machine Co. Inc. Food package with integral juice absorbing bottom
US20030070232A1 (en) 2001-10-12 2003-04-17 Darlene Diak/Ghanem Quick change bedsheet set
US20040074271A1 (en) 2002-10-15 2004-04-22 Krysiak Michael Dennis Soil stabilizer carrier
US7732657B2 (en) 2002-12-20 2010-06-08 The Procter & Gamble Company Absorbent article with lotion-containing topsheet
US20040128764A1 (en) 2003-01-06 2004-07-08 Mcgrath Deborah Easily changeable absorbent panel for bed clothing
US20050008737A1 (en) 2003-07-07 2005-01-13 Young-Won Kwon Absorbent pad for absorbing liquid exuding from food
US7670513B2 (en) 2003-07-23 2010-03-02 Basf Aktiengesellschaft Fire control composition and method
US9297737B2 (en) 2004-03-06 2016-03-29 Michael Trainer Methods and apparatus for determining characteristics of particles
US20050256486A1 (en) 2004-05-14 2005-11-17 Carasso Samuel C Fluid management device with fluid transport element for use within a body
US8859758B2 (en) 2004-06-21 2014-10-14 Evonik Degussa Gmbh Water-absorbing polymer
US7459501B2 (en) 2004-08-27 2008-12-02 Absorbent Technologies, Inc. Superabsorbent polymers in agricultural applications
US20060172048A1 (en) 2005-01-21 2006-08-03 Etchells Marc D Food preservation systems
US8912383B2 (en) 2005-04-29 2014-12-16 Kimberly-Clark Worldwide, Inc. Dual mode absorbent tampon
US20120328723A1 (en) 2006-01-25 2012-12-27 Absorbent Technologies, Inc. Methods for producing superabsorbent polymers for use in agricultural applications
US20070287971A1 (en) 2006-03-31 2007-12-13 The Procter & Gamble Company Absorbent articles with feedback signal upon urination
US20100241098A1 (en) 2006-08-02 2010-09-23 James Roy Brownlee Diapering system using re-usable diaper shell with replaceable absorbent insert and method of manufacture of same
US20080112907A1 (en) 2006-11-03 2008-05-15 Chan Anita N Dispersible cationic polygalactomannan polymers for use in personal care and household care applications
US7567739B2 (en) 2007-01-31 2009-07-28 Draka Comteq B.V. Fiber optic cable having a water-swellable element
US20080199577A1 (en) 2007-02-21 2008-08-21 Paper-Pak Industries Consumer food storage package with absorbent food pad
US20130281949A1 (en) 2007-10-12 2013-10-24 Lori Lee Periman Potty training liners
US20110137277A1 (en) 2008-07-07 2011-06-09 Dry Like Me Limited Absorbent pad
US9161860B2 (en) 2009-08-24 2015-10-20 Paper-Pak Industries Removable absorbent pad for transporter
US20130018112A1 (en) 2009-09-14 2013-01-17 University Of Nottingham Cellulose nanoparticle aerogels, hydrogels and organogels
US9089730B2 (en) 2010-11-25 2015-07-28 Zzakey Technologies Ltd Biodegradable fire-fighting formulation
US20130244288A1 (en) 2011-09-09 2013-09-19 E I Du Pont De Nemours And Company High titer production of poly (alpha 1,3 glucan)
US8871474B2 (en) 2012-09-25 2014-10-28 E. I. Du Pont De Nemours And Company Glucosyltransferase enzymes for production of glucan polymers
US20170283568A1 (en) 2013-04-10 2017-10-05 Lenzing Ag Polysaccharide film and method for the production thereof
US20160068650A1 (en) 2013-05-03 2016-03-10 National University Of Singapore Polysaccharide aerogel
US20160177471A1 (en) 2013-06-18 2016-06-23 Lenzing Ag Polysaccharide fibers and method for producing same
US20150064748A1 (en) 2013-09-05 2015-03-05 E I Du Pont De Nemours And Company Process for producing aplha-1,3-glucan polymer with reduced molecular weight
US8987543B1 (en) 2013-10-30 2015-03-24 Lillian A. Watson Sizeable sanitary or incontinence pad with med alerts
US20160304629A1 (en) 2013-12-16 2016-10-20 E. I. Du Pont De Nemours And Company Use of poly alpha-1,3-glucan ethers as viscosity modifiers
US20160311935A1 (en) 2013-12-18 2016-10-27 E. I. Du Pont De Nemours And Company Cationic poly alpha-1,3-glucan ethers
US20150191550A1 (en) 2014-01-06 2015-07-09 E I Du Pont De Nemours And Company Production of poly alpha-1,3-glucan films
US20160333157A1 (en) 2014-01-17 2016-11-17 E. I. Du Pont De Nemours And Company Production of a solution of cross-linked poly alpha-1,3-glucan and poly alpha-1,3-glucan film made therefrom
US10260053B2 (en) 2014-02-14 2019-04-16 E I Du Pont De Nemours And Company Glucosyltransferase enzymes for production of glucan polymers
US20150232819A1 (en) 2014-02-14 2015-08-20 E I Du Pont De Nemours And Company Glucosyltransferase enzymes for production of glucan polymers
US20150232785A1 (en) 2014-02-14 2015-08-20 E I Du Pont De Nemours And Company Polysaccharides for viscosity modification
US20150368595A1 (en) 2014-06-19 2015-12-24 E I Du Pont De Nemours And Company Compositions containing one or more poly alpha-1,3-glucan ether compounds
US20150368594A1 (en) 2014-06-19 2015-12-24 E I Du Pont De Nemours And Company Compositions containing one or more poly alpha-1,3-glucan ether compounds
WO2015200612A1 (fr) 2014-06-26 2015-12-30 E. I. Du Pont De Nemours And Company Production de boyaux à usage alimentaire à base de poly(alpha-1,3-glucane)
WO2015200590A1 (fr) 2014-06-26 2015-12-30 E.I. Du Pont De Nemours And Company Compositions de solution de poly(alpha -1,3-glucane)
US20170204203A1 (en) 2014-06-26 2017-07-20 E. I. Du Pont De Nemours And Company Poly alpha-1,3-glucan solution compositions
US20170208823A1 (en) 2014-06-26 2017-07-27 E I Du Pont De Nemours And Company Production of poly alpha-1,3-glucan food casings
US20160058045A1 (en) 2014-08-26 2016-03-03 Pepsico, Inc. Method of Loading Flavor into an Aerogel and Flavor Impregnated Aerogel Based on Food Grade Materials
US20160122445A1 (en) 2014-11-05 2016-05-05 E I Du Pont De Nemours And Company Enzymatically polymerized gelling dextrans
US20160175811A1 (en) 2014-12-22 2016-06-23 E I Du Pont De Nemours And Company Polysaccharide compositions for absorbing aqueous liquid
US20180021238A1 (en) 2015-02-06 2018-01-25 E I Du Pont De Nemours And Company Colloidal dispersions of poly alpha-1,3-glucan based polymers
US20180273731A1 (en) 2015-02-06 2018-09-27 Lenzing Ag Polysaccharide suspension, method for its preparation, and use thereof
WO2016133734A1 (fr) 2015-02-18 2016-08-25 E. I. Du Pont De Nemours And Company Éthers polysaccharidiques de soja
US20180237816A1 (en) 2015-04-03 2018-08-23 E I Du Pont De Nemours And Company Gelling dextran ethers
US20180022834A1 (en) 2015-04-03 2018-01-25 E I Du Pont De Nemours And Company Oxidized dextran
US20180079832A1 (en) 2015-04-03 2018-03-22 E I Du Pont De Nemours And Company Oxidized soy polysaccharide
US20170002335A1 (en) 2015-06-17 2017-01-05 E I Du Pont De Nemours And Company Glucosyltransferase amino acid motifs for enzymatic production of linear poly alpha-1,3-glucan
US20170002336A1 (en) 2015-06-17 2017-01-05 E I Du Pont De Nemours And Company Modified glucosyltransferases for producing branched alpha-glucan polymers
US20180230241A1 (en) 2015-08-28 2018-08-16 E I Du Pont De Nemours And Company Benzyl alpha-(1->3)-glucan and fibers thereof
US20200165360A1 (en) 2015-11-05 2020-05-28 E I Du Pont De Nemours And Company Dextran-poly alpha-1,3-glucan graft copolymers and synthesis methods thereof
US20190309096A1 (en) 2016-06-13 2019-10-10 E I Du Pont De Nemours And Company Detergent compositions
US20190202942A1 (en) 2016-06-13 2019-07-04 E I Du Pont De Nemours And Company Detergent compositions
US20190225737A1 (en) 2016-07-22 2019-07-25 E I Du Pont De Nemours And Company Polyurethane polymers comprising polysaccharides
US10301604B2 (en) 2016-09-14 2019-05-28 E I Du Pont De Nemours And Company Engineered glucosyltransferases
US20180340199A1 (en) 2017-05-23 2018-11-29 E I Du Pont De Nemours And Company Enzymatic production of alpha-1,3-glucan
US20190078062A1 (en) 2017-09-13 2019-03-14 E I Du Pont De Nemours And Company Engineered glucosyltransferases
US20190078063A1 (en) 2017-09-13 2019-03-14 E I Du Pont De Nemours And Company Engineered glucosyltransferases
US20190112456A1 (en) 2017-10-13 2019-04-18 E I Du Pont De Nemours And Company Flowable bulk granular polysaccharide
US20190185893A1 (en) 2017-12-14 2019-06-20 E I Du Pont De Nemours And Company Alpha-1,3-glucan graft copolymers
US11098334B2 (en) 2017-12-14 2021-08-24 Nutrition & Biosciences USA 4, Inc. Alpha-1,3-glucan graft copolymers
WO2019167013A1 (fr) 2018-03-02 2019-09-06 Materias S.R.L. Procédé de préparation d'un aérogel superabsorbant
US20190276806A1 (en) 2018-03-09 2019-09-12 E I Du Pont De Nemours And Company Engineered glucosyltransferases
US20200131281A1 (en) 2018-10-25 2020-04-30 Dupont Industrial Biosciences Usa, Llc Alpha-1,3-glucan graft copolymers
WO2022235655A1 (fr) 2021-05-04 2022-11-10 Nutrition & Biosciences USA 4, Inc. Compositions comprenant un alpha-glucane insoluble
WO2023183280A1 (fr) 2022-03-21 2023-09-28 Nutrition & Biosciences USA 4, Inc. Compositions comprenant un alpha-glucane insoluble

Non-Patent Citations (4)

* Cited by examiner, † Cited by third party
Title
CHUNPARK, MACROMOL. CHEM. PHYS., vol. 195, pages 701 - 711
S. W. CUI: "Structural Analysis of Polysaccharides", 2005, TAYLOR & FRANCIS GROUP LLC, article "Food Carbohydrates: Chemistry, Physical Properties, and Applications"
SIMPSON ET AL., MICROBIOLOGY, vol. 141, 1995, pages 1451 - 1460
WEAVER ET AL., J. APPL. POLYM. SCI., vol. 35, pages 1631 - 1637

Also Published As

Publication number Publication date
WO2025006691A3 (fr) 2025-02-27

Similar Documents

Publication Publication Date Title
Mndlovu et al. Development of a fluid-absorptive alginate-chitosan bioplatform for potential application as a wound dressing
Doh et al. Manufacturing and analyses of wet-laid nonwoven consisting of carboxymethyl cellulose fibers
US5550189A (en) Modified polysaccharides having improved absorbent properties and process for the preparation thereof
JP5581328B2 (ja) 液体吸収材
US8975387B1 (en) Modified carbohydrate-chitosan compounds, methods of making the same and methods of using the same
CA2335563C (fr) Pansements et materiaux constitutifs adaptes
JP2020533498A (ja) 多糖を含む不織ウェブ
US20040265371A1 (en) Hemostatic devices and methods of making same
WO2016158976A1 (fr) Agent particulaire absorbant l'eau
ES2962645T3 (es) Lámina hemostática biocompatible y flexible
JP2001520274A (ja) 発泡材料
US20210322225A1 (en) Lint Free Crosslinked Chitosan-PVA Sponge as an Absorbent Wound Dressing and Method of Preparation Thereof
JP2012509947A (ja) 吸水性多糖類及びその製造方法
US20150376300A1 (en) Biodegradable superabsorbent hydrogels
EP1119378B1 (fr) Materiau polymere absorbant a base de polysaccharide
WO2016067250A1 (fr) Dispositifs hémostatiques à propriétés améliorées et leurs procédés de fabrication
AU2001255496A1 (en) Polysaccharide absorbent and method
JPWO2018135139A1 (ja) 高分子および高分子膜の製造方法
WO2025006691A2 (fr) Compositions poreuses d'alpha-1,3-glucane
Sangeetha et al. Tough gels and macroporous foams based on chitosan through hydrothermal synthesis of chitosan, tartaric acid, and urea
Nicu et al. Tailoring the structure and physico-chemical features of cellulose-based hydrogels using multi-epoxy crosslinking agents
US20120197164A1 (en) Ultrasound couplant
Lee et al. Structure and liquid handling properties of water-insoluble carboxymethyl cellulose foam
CN117164894A (zh) 一种卫生巾用交联羧甲基纤维素超吸水凝胶及其制备方法
Biranje et al. Nanoscale chitosan-based hemostasis membrane

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 24746479

Country of ref document: EP

Kind code of ref document: A2